image,caption
../abc\AKT\23885909_page5_123_0.jpg,Lapatinib a SMKI promotes apoptosis by inhibiting activation of EGFR andHER-2 and the downstream pathways PI3K AKT mTORand RAS RAF MAPK 45
../abc\AKT\25101240_page1_4_0.jpg,The exact mechanism by which the ALK receptor inducesactivation of the mTOR pathway remains to be elucidated butinhibition of AKT by phosphorylation seems to play a key factor
../abc\AKT\25505733_page1_4_0.jpg,Phosphorylated Akt overexpression andloss of PTEN expression in non-small cell lung cancer confers poor prognosis
../abc\AKT\25557115_page3_13_0.jpg,Drugs against the PI3K AKT and RAF-MEK-ERK pathways are used for the treatment of patients carrying RAS mutations
../abc\AKT\26579470_page1_13_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\AKT\26579470_page1_13_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\AKT\26579470_page1_13_0.jpg,Loss of PTENmTOR inhibitors AKT inhibitors––PIK3CA mutationEGFR-TKIsþPI3K inhibitorsGeﬁtinibþBKM12096
../abc\AKT\26579470_page2_41_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\AKT\26579470_page2_41_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\AKT\26579470_page2_41_0.jpg,Loss of PTENmTOR inhibitors AKT inhibitors––PIK3CA mutationEGFR-TKIsþPI3K inhibitorsGeﬁtinibþBKM12096
../abc\AKT\26579470_page3_62_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\AKT\26579470_page3_62_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\AKT\26579470_page3_62_0.jpg,Loss of PTENmTOR inhibitors AKT inhibitors––PIK3CA mutationEGFR-TKIsþPI3K inhibitorsGeﬁtinibþBKM12096
../abc\AKT\26579470_page6_135_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\AKT\26579470_page6_135_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\AKT\26579470_page6_135_0.jpg,Loss of PTENmTOR inhibitors AKT inhibitors––PIK3CA mutationEGFR-TKIsþPI3K inhibitorsGeﬁtinibþBKM12096
../abc\AKT\26579470_page7_156_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\AKT\26579470_page7_156_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\AKT\26579470_page7_156_0.jpg,Loss of PTENmTOR inhibitors AKT inhibitors––PIK3CA mutationEGFR-TKIsþPI3K inhibitorsGeﬁtinibþBKM12096
../abc\AKT\26675306_page3_47_0.jpg,Rapamycin induces feedback activation of Akt signaling through anIGF-1R-dependent mechanism Oncogene 26 13 2007 1932–1940
../abc\AKT\26675306_page3_47_0.jpg,Initial testing stage 1 of the Akt inhibitor GSK690693 by the pedi-atric preclinical testing program Pediatr
../abc\AKT\26675306_page3_47_0.jpg,Testing of the Akt PKB inhibitor MK-2206 by the Pediatric Preclin-ical Testing Program Pediatr
../abc\AKT\26891293_page8_281_0.jpg,NVP-BEZ235 overcomesgeﬁtinib-acquired resistance by down-regulating PI3K AKT mTOR phosphorylation
../abc\AKT\26891293_page8_281_0.jpg,Resveratrol reducesprostate cancer growth and metastasis by inhibiting the Akt MicroRNA-21 pathway
../abc\AKT\27843613_page2_48_0.jpg,In particular AKT activation can be tied toAKT gene mutation mutations and ampliﬁcations ofPIK3CA the gene encoding the main catalytic subunitof PI3K as well as loss or reduced expression of PTEN
../abc\AKT\27994551_page3_338_0.jpg,As Akt signalingand mitochondrial biology both participate in the physiologicalbehaviors the clinical use of their corresponding inhibitors wouldcause side eﬀects in a certain extent
../abc\AKT\27994551_page3_338_0.jpg,AKT signaling in ERBB2-ampliﬁed breast cancer
../abc\AKT\27994551_page3_338_0.jpg,AKT inhibition relieves feedback suppressionof receptor tyrosine kinase expression and activity
../abc\AKT\27994551_page3_338_0.jpg,HEATR1 negatively regulates Akt to help sensitize pancreatic cancer cells tochemotherapy
../abc\AKT\27994551_page3_338_0.jpg,AKT PKB signaling: navigatingdownstream
../abc\AKT\27994551_page3_338_1.jpg,As Akt signalingand mitochondrial biology both participate in the physiologicalbehaviors the clinical use of their corresponding inhibitors wouldcause side eﬀects in a certain extent
../abc\AKT\27994551_page3_338_1.jpg,AKT signaling in ERBB2-ampliﬁed breast cancer
../abc\AKT\27994551_page3_338_1.jpg,AKT inhibition relieves feedback suppressionof receptor tyrosine kinase expression and activity
../abc\AKT\27994551_page3_338_1.jpg,HEATR1 negatively regulates Akt to help sensitize pancreatic cancer cells tochemotherapy
../abc\AKT\27994551_page3_338_1.jpg,AKT PKB signaling: navigatingdownstream
../abc\AKT\28443282_page1_4_0.jpg,This study involved eight investigational arms—AZD5363 AKT inhibitor  AZD 4547 FGFR inhibitor  AZD2014 mTORC1 2 inhibitor  palbocilib CDK4 6 inhibitor; Pfizer  crizotinib AZD9291 third-generation EGFR inhibitor  selumetinib MEK inhibitor + docetaxel and durvalumab anti PD-L1 monoclonal antibody
../abc\AKT\28443282_page1_4_0.jpg,Other investigational drugs include taselisib PI3K inhibitor  GSK2636771 PI3K inhibitor; Glaxo-Smith Kline  defactinib FAK inhibitor; Verastem  AZD4547 FGFR inhibitor  AZD5363 AKT inhibitor  and binimetinib MEK inhibitor; Array Biopharma
../abc\AKT\29734788_page14_234_0.jpg,Akt phosphorylates the Yes-associated protein YAP to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
../abc\AKT\29734788_page14_234_0.jpg,Anexelekto AXL increases resistance to EGFR-TKI and activation of AKT and ERK1 2 in non-small cell lung cancer cells
../abc\AKT\29734788_page14_234_1.jpg,Akt phosphorylates the Yes-associated protein YAP to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
../abc\AKT\29734788_page14_234_1.jpg,Anexelekto AXL increases resistance to EGFR-TKI and activation of AKT and ERK1 2 in non-small cell lung cancer cells
../abc\AKT\29734788_page6_128_0.jpg,Akt phosphorylates the Yes-associated protein YAP to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
../abc\AKT\29734788_page6_128_0.jpg,Anexelekto AXL increases resistance to EGFR-TKI and activation of AKT and ERK1 2 in non-small cell lung cancer cells
../abc\AKT\29973561_page9_473_0.jpg,Metformin decreases IL-6 signaling reverses EMT and decreases activation of STAT3 and AKT [61 78]
../abc\AKT\31366041_page3_297_0.jpg,"Ras ERK, PI3K Akt and JAK STAT pathways that cumulatively resultin increased proliferation and reduced apoptosis of transformed cells [145]"
../abc\AKT\31366041_page3_297_0.jpg,Involvement of PI3K Akt pathway in cell cycle progression apoptosis and neoplastic transformation: Atarget for cancer chemotherapy
../abc\AKT\31366041_page3_297_0.jpg,Akt phosphorylation of BADcouples survival signals to the cell-intrinsic death machinery
../abc\AKT\31438559_page2_103_0.jpg,ADAM17 regulates prostate cancer cellproliferation through mediating cell cycle progression by EGFR PI3K AKT pathway
../abc\AKT\31438559_page5_145_0.jpg,ADAM17 regulates prostate cancer cellproliferation through mediating cell cycle progression by EGFR PI3K AKT pathway
../abc\AKT\31527477_page3_324_0.jpg,CombinedInhibitions of Glycolysis and AKT autophagy Can Overcome Resistance to EGFR-targeted Therapy of LungCancer
../abc\AKT\31527477_page3_324_0.jpg,Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-MediatedPI3K AKT mTOR and ERK p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
../abc\AKT\31527477_page3_324_0.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\AKT\31527477_page3_324_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\AKT\31527477_page5_424_0.jpg,CombinedInhibitions of Glycolysis and AKT autophagy Can Overcome Resistance to EGFR-targeted Therapy of LungCancer
../abc\AKT\31527477_page5_424_0.jpg,Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-MediatedPI3K AKT mTOR and ERK p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
../abc\AKT\31527477_page5_424_0.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\AKT\31527477_page5_424_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\AKT\31527477_page7_566_0.jpg,CombinedInhibitions of Glycolysis and AKT autophagy Can Overcome Resistance to EGFR-targeted Therapy of LungCancer
../abc\AKT\31527477_page7_566_0.jpg,Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-MediatedPI3K AKT mTOR and ERK p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
../abc\AKT\31527477_page7_566_0.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\AKT\31527477_page7_566_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\AKT\31871778_page1_75_0.jpg,MiR-93 promotes tumorigenesis and metastasis ofnon-small cell lung cancer cells by activating the PI3K Akt pathway via Inhibi-tion of LKB1 PTEN CDKN1A
../abc\AKT\31871778_page1_75_0.jpg,miRNA-223 is an anticancer gene in human non-small cell lungcancer through the PI3K AKT pathway by targeting EGFR
../abc\AKT\31871778_page1_75_0.jpg,Targeting PI3K AKT mTOR pathway in non small cell lung cancer
../abc\AKT\31871778_page1_75_0.jpg,PI3K Akt signalling pathway and cancer
../abc\AKT\31871778_page1_75_0.jpg,PTEN and PI3K AKT in non-small-cell lung cancer
../abc\AKT\31871778_page1_75_0.jpg,Inhibition of miR-23a increases the sensitivity of lung cancer stemcells to erlotinib through PTEN PI3K Akt pathway
../abc\AKT\31920650_page3_84_0.jpg,3 and microRNA-19a is involved in the development ofchemoresistance to cisplatin via modulating signaling pathway of PTEN AKT
../abc\AKT\31988639_page10_712_0.jpg,Negative Regulation of AKT Activation by BRCA1
../abc\AKT\31988639_page10_712_0.jpg,Akt is negatively regulated by theMULAN E3 ligase
../abc\AKT\31988639_page10_712_0.jpg,PTEN lossdefines a PI3K AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
../abc\AKT\31988639_page10_712_0.jpg,PI3K PTEN Akt and TSC mTOR signaling pathways ovarian dysfunction and infertility: anupdate
../abc\AKT\31988639_page10_712_0.jpg,The PTEN PI3K AKT Pathway in vivo
../abc\AKT\31988639_page10_712_0.jpg,PTEN modulates cell cycleprogression and cell survival by regulating phosphatidylinositol 3 4 5 -trisphosphate and Akt protein kinase B signalingpathway
../abc\AKT\31988639_page10_712_0.jpg,Deregulation of the EGFR PI3K PTEN Akt mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
../abc\AKT\31988639_page10_712_0.jpg,Phosphorylation and regulation of Raf by Akt protein kinase B
../abc\AKT\31988639_page10_712_0.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\AKT\31988639_page9_694_0.jpg,Negative Regulation of AKT Activation by BRCA1
../abc\AKT\31988639_page9_694_0.jpg,Akt is negatively regulated by theMULAN E3 ligase
../abc\AKT\31988639_page9_694_0.jpg,PTEN lossdefines a PI3K AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
../abc\AKT\31988639_page9_694_0.jpg,PI3K PTEN Akt and TSC mTOR signaling pathways ovarian dysfunction and infertility: anupdate
../abc\AKT\31988639_page9_694_0.jpg,The PTEN PI3K AKT Pathway in vivo
../abc\AKT\31988639_page9_694_0.jpg,PTEN modulates cell cycleprogression and cell survival by regulating phosphatidylinositol 3 4 5 -trisphosphate and Akt protein kinase B signalingpathway
../abc\AKT\31988639_page9_694_0.jpg,Deregulation of the EGFR PI3K PTEN Akt mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
../abc\AKT\31988639_page9_694_0.jpg,Phosphorylation and regulation of Raf by Akt protein kinase B
../abc\AKT\31988639_page9_694_0.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\AKT\31988639_page9_694_1.jpg,Negative Regulation of AKT Activation by BRCA1
../abc\AKT\31988639_page9_694_1.jpg,Akt is negatively regulated by theMULAN E3 ligase
../abc\AKT\31988639_page9_694_1.jpg,PTEN lossdefines a PI3K AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
../abc\AKT\31988639_page9_694_1.jpg,PI3K PTEN Akt and TSC mTOR signaling pathways ovarian dysfunction and infertility: anupdate
../abc\AKT\31988639_page9_694_1.jpg,The PTEN PI3K AKT Pathway in vivo
../abc\AKT\31988639_page9_694_1.jpg,PTEN modulates cell cycleprogression and cell survival by regulating phosphatidylinositol 3 4 5 -trisphosphate and Akt protein kinase B signalingpathway
../abc\AKT\31988639_page9_694_1.jpg,Deregulation of the EGFR PI3K PTEN Akt mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
../abc\AKT\31988639_page9_694_1.jpg,Phosphorylation and regulation of Raf by Akt protein kinase B
../abc\AKT\31988639_page9_694_1.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\AKT\32549388_page2_94_0.jpg,Some miRNAs can promote TKI resistance via activating the PI3K AKT mTOR signaling pathways
../abc\AKT\32549388_page2_94_0.jpg,miR-21 and miR-23a can target PTEN and then activate AKT resulting in resistance to TKIs in NSCLC cells [111 112]
../abc\AKT\32549388_page2_94_0.jpg,miR-21 and KLF4 jointly augmentepithelial-mesenchymal transition via the Akt ERK1 2 pathway
../abc\AKT\32549388_page2_94_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\AKT\32560574_page2_100_0.jpg,Hyperactivation of RAF MEK ERK RSK and PI3K AKT mTOR pathways was deﬁned asa key resistance mechanism to ganetespib [103]
../abc\AKT\32560574_page2_100_0.jpg,Antitumor activity in ras-driven tumors by blocking akt and mek
../abc\AKT\32666476_page5_83_0.jpg,Allosteric modulation of Ras and the PI3K AKT mTOR pathway: emerging therapeutic opportunities
../abc\AKT\33024658_page1_35_0.jpg,Bone metastasis in renal cell carcinoma ispreprogrammed in the primary tumor and caused by AKT and integrin alpha5signaling J
../abc\AKT\33419029_page7_111_0.jpg,"The four major receptors groups RTKs PDGFR c-KIT and VEGFR closely regulate the cellular process such as angiogenesis cell proliferation and motility and anti-apoptotic capability of cancer cells through the induction of RAF MEK ERK, PI3K AKT mTOR, PKC and Src FAK axis"
../abc\AKT\33562150_page1_85_0.jpg,"Althoughdirect evidence of the PD-L1-regulated MERTK signaling pathway is lacking a studyof the PD-L1 signalosome showed that the intracellular domain of PD-L1 may interactwith molecules that are involved in Akt mTOR, the DNA damage response and theanti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page1_85_0.jpg,"Although direct evidence of the PD-L1-regulated MERTK signaling pathway is lacking a study of the PD-L1 signal-osome showed that the intracellular domain of PD-L1 may interact with molecules that are involved in Akt mTOR, the DNA damage response and the anti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page1_85_0.jpg,M2 macrophages reduce the effect of geﬁtinib by activating Akt mTOR ingeﬁtinib-resistant cell lines HCC827 GR
../abc\AKT\33562150_page2_105_0.jpg,"Althoughdirect evidence of the PD-L1-regulated MERTK signaling pathway is lacking a studyof the PD-L1 signalosome showed that the intracellular domain of PD-L1 may interactwith molecules that are involved in Akt mTOR, the DNA damage response and theanti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page2_105_0.jpg,"Although direct evidence of the PD-L1-regulated MERTK signaling pathway is lacking a study of the PD-L1 signal-osome showed that the intracellular domain of PD-L1 may interact with molecules that are involved in Akt mTOR, the DNA damage response and the anti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page2_105_0.jpg,M2 macrophages reduce the effect of geﬁtinib by activating Akt mTOR ingeﬁtinib-resistant cell lines HCC827 GR
../abc\AKT\33562150_page4_139_0.jpg,"Althoughdirect evidence of the PD-L1-regulated MERTK signaling pathway is lacking a studyof the PD-L1 signalosome showed that the intracellular domain of PD-L1 may interactwith molecules that are involved in Akt mTOR, the DNA damage response and theanti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page4_139_0.jpg,"Although direct evidence of the PD-L1-regulated MERTK signaling pathway is lacking a study of the PD-L1 signal-osome showed that the intracellular domain of PD-L1 may interact with molecules that are involved in Akt mTOR, the DNA damage response and the anti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page4_139_0.jpg,M2 macrophages reduce the effect of geﬁtinib by activating Akt mTOR ingeﬁtinib-resistant cell lines HCC827 GR
../abc\AKT\33562150_page9_195_0.jpg,"Althoughdirect evidence of the PD-L1-regulated MERTK signaling pathway is lacking a studyof the PD-L1 signalosome showed that the intracellular domain of PD-L1 may interactwith molecules that are involved in Akt mTOR, the DNA damage response and theanti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page9_195_0.jpg,"Although direct evidence of the PD-L1-regulated MERTK signaling pathway is lacking a study of the PD-L1 signal-osome showed that the intracellular domain of PD-L1 may interact with molecules that are involved in Akt mTOR, the DNA damage response and the anti-apoptosis pathway [142 146]"
../abc\AKT\33562150_page9_195_0.jpg,M2 macrophages reduce the effect of geﬁtinib by activating Akt mTOR ingeﬁtinib-resistant cell lines HCC827 GR
../abc\EGFR\25505733_page1_4_0.jpg,Striking therapeutic advances in metastatic NSCLC have beenobserved with targeted agents using molecular selection notablefor patients with EGFR mutant or ALK-rearranged lung can-cer
../abc\EGFR\25505733_page1_4_0.jpg,A prospec-tive molecular epidemiology study of EGFR mutations in Asian patients withadvanced non-small-cell lung cancer of adenocarcinoma histology PIONEER
../abc\EGFR\25505733_page1_4_0.jpg,Clini-cal activity of the mutant-selective EGFR inhibitor AZD9291 in patients pts with EGFR inhibitor-resistant non-small cell lung cancer NSCLC
../abc\EGFR\25505733_page1_4_0.jpg,First-in-human evaluation of CO-1686 an irreversible highly selective tyrosinekinase inhibitor of mutations of EGFR activating and T790M
../abc\EGFR\25505733_page1_4_0.jpg,Aphase II study of HSP90 inhibitor AUY922 and erlotinib for patients with EGFR-mutant lung cancer and acquired resistance to EGFR tyrosine kinase inhibitors
../abc\EGFR\25505733_page1_4_0.jpg,Roleof KRAS and EGFR as biomarkers of response to erlotinib in National Can-cer Institute of Canada clinical trials group study BR
../abc\EGFR\28348561_page4_158_0.jpg,Molecular epidemiology of lung cancer and geographic varia-tions with special reference to EGFR mutations
../abc\EGFR\28348561_page4_158_0.jpg,Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-pos-itive non-small-cell lung cancer LUX-Lung 7 : a Phase 2B open-label randomised controlled trial
../abc\EGFR\28348561_page4_158_0.jpg,Paracrine network: another step in the com-plexity of resistance to EGFR blockade? Clin Cancer Res 2014 20 24 :6227–9
../abc\EGFR\29973561_page2_202_0.jpg,Local therapy with continued egfr tyrosine kinase inhibitor therapy as a treatment strategyin egfr-mutant advanced lung cancers that have developed acquired resistance to egfr tyrosine kinaseinhibitors
../abc\EGFR\29973561_page2_202_0.jpg,The t790m “gatekeeper” mutation in EGFR mediates resistance to low concentrations of anirreversible egfr inhibitor
../abc\EGFR\29973561_page2_202_0.jpg,The role of egfr inhibition in the treatment of non-small cell lung cancer
../abc\EGFR\29973561_page2_202_0.jpg,Azd9291 in EGFR inhibitor-resistant non-small-cell lung cancer
../abc\EGFR\29973561_page2_202_0.jpg,Antitumor activity of osimertinib an irreversible mutant-selective EGFRtyrosine kinase inhibitor in nsclc harboring egfr exon 20 insertions
../abc\EGFR\29973561_page2_202_0.jpg,Egfr-independentmechanisms of acquired resistance to azd9291 in egfr t790m-positive nsclc patients
../abc\EGFR\29973561_page2_202_0.jpg,EGFR g796dmutation mediates resistance to osimertinib
../abc\EGFR\29973561_page2_202_0.jpg,EGFR c797s mutation mediates resistance to third-generationinhibitors in t790m-positive non-small cell lung cancer
../abc\EGFR\29973561_page2_202_0.jpg,Eai045: The fourth-generation egfr inhibitor overcoming t790m and c797sresistance
../abc\EGFR\29973561_page2_202_0.jpg,Activating and resistance mutations of egfr in non-small-cell lung cancer: Role in clinicalresponse to EGFR tyrosine kinase inhibitors
../abc\EGFR\29973561_page2_202_0.jpg,T790m and acquired resistance of EGFR TKI: A literature review of clinical reports
../abc\EGFR\29973561_page2_202_0.jpg,Alternative signalingpathways as potential therapeutic targets for overcoming egfr and c-met inhibitor resistance in non-smallcell lung cancer
../abc\EGFR\29973561_page2_202_0.jpg,Mechanism of resistance and novel targetsmediating resistance to egfr and c-met tyrosine kinase inhibitors in non-small cell lung cancer
../abc\EGFR\29973561_page2_202_0.jpg,HER2 kinase domain mutation results in constitutive phosphorylation andactivation of HER2 and EGFR and resistance to egfr tyrosine kinase inhibitors
../abc\EGFR\29973561_page2_202_0.jpg,Synergism of EGFR and c-MET pathways cross-talk and inhibition in non-small celllung cancer
../abc\EGFR\29973561_page2_202_0.jpg,Combined therapy with mutant-selective EGFR inhibitor and MET kinaseinhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer
../abc\EGFR\29973561_page2_202_0.jpg,Combinedinhibition of igfr enhances the effects of geﬁtinib in h1650: A lung cancer cell line with egfr mutation andprimary resistance to EGFR-TK inhibitors
../abc\EGFR\29973561_page2_202_0.jpg,Synergistic effects of metformin treatment in combination with geﬁtinib a selective egfr tyrosine kinase inhibitor in LKB1 wild-type nsclc cell lines
../abc\EGFR\29973561_page2_202_0.jpg,Activation of signal transducer and activator of transcription 3 STAT3 signaling in egfr mutant non-small-cell lung cancer NSCLC
../abc\EGFR\29973561_page2_202_0.jpg,Acquired resistance to the mutant-selective EGFR inhibitor azd9291 is associatedwith increased dependence on Ras signaling in preclinical models
../abc\EGFR\29973561_page4_305_0.jpg,Local therapy with continued egfr tyrosine kinase inhibitor therapy as a treatment strategyin egfr-mutant advanced lung cancers that have developed acquired resistance to egfr tyrosine kinaseinhibitors
../abc\EGFR\29973561_page4_305_0.jpg,The t790m “gatekeeper” mutation in EGFR mediates resistance to low concentrations of anirreversible egfr inhibitor
../abc\EGFR\29973561_page4_305_0.jpg,The role of egfr inhibition in the treatment of non-small cell lung cancer
../abc\EGFR\29973561_page4_305_0.jpg,Azd9291 in EGFR inhibitor-resistant non-small-cell lung cancer
../abc\EGFR\29973561_page4_305_0.jpg,Antitumor activity of osimertinib an irreversible mutant-selective EGFRtyrosine kinase inhibitor in nsclc harboring egfr exon 20 insertions
../abc\EGFR\29973561_page4_305_0.jpg,Egfr-independentmechanisms of acquired resistance to azd9291 in egfr t790m-positive nsclc patients
../abc\EGFR\29973561_page4_305_0.jpg,EGFR g796dmutation mediates resistance to osimertinib
../abc\EGFR\29973561_page4_305_0.jpg,EGFR c797s mutation mediates resistance to third-generationinhibitors in t790m-positive non-small cell lung cancer
../abc\EGFR\29973561_page4_305_0.jpg,Eai045: The fourth-generation egfr inhibitor overcoming t790m and c797sresistance
../abc\EGFR\29973561_page4_305_0.jpg,Activating and resistance mutations of egfr in non-small-cell lung cancer: Role in clinicalresponse to EGFR tyrosine kinase inhibitors
../abc\EGFR\29973561_page4_305_0.jpg,T790m and acquired resistance of EGFR TKI: A literature review of clinical reports
../abc\EGFR\29973561_page4_305_0.jpg,Alternative signalingpathways as potential therapeutic targets for overcoming egfr and c-met inhibitor resistance in non-smallcell lung cancer
../abc\EGFR\29973561_page4_305_0.jpg,Mechanism of resistance and novel targetsmediating resistance to egfr and c-met tyrosine kinase inhibitors in non-small cell lung cancer
../abc\EGFR\29973561_page4_305_0.jpg,HER2 kinase domain mutation results in constitutive phosphorylation andactivation of HER2 and EGFR and resistance to egfr tyrosine kinase inhibitors
../abc\EGFR\29973561_page4_305_0.jpg,Synergism of EGFR and c-MET pathways cross-talk and inhibition in non-small celllung cancer
../abc\EGFR\29973561_page4_305_0.jpg,Combined therapy with mutant-selective EGFR inhibitor and MET kinaseinhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer
../abc\EGFR\29973561_page4_305_0.jpg,Combinedinhibition of igfr enhances the effects of geﬁtinib in h1650: A lung cancer cell line with egfr mutation andprimary resistance to EGFR-TK inhibitors
../abc\EGFR\29973561_page4_305_0.jpg,Synergistic effects of metformin treatment in combination with geﬁtinib a selective egfr tyrosine kinase inhibitor in LKB1 wild-type nsclc cell lines
../abc\EGFR\29973561_page4_305_0.jpg,Activation of signal transducer and activator of transcription 3 STAT3 signaling in egfr mutant non-small-cell lung cancer NSCLC
../abc\EGFR\29973561_page4_305_0.jpg,Acquired resistance to the mutant-selective EGFR inhibitor azd9291 is associatedwith increased dependence on Ras signaling in preclinical models
../abc\EGFR\29973561_page4_305_1.jpg,Local therapy with continued egfr tyrosine kinase inhibitor therapy as a treatment strategyin egfr-mutant advanced lung cancers that have developed acquired resistance to egfr tyrosine kinaseinhibitors
../abc\EGFR\29973561_page4_305_1.jpg,The t790m “gatekeeper” mutation in EGFR mediates resistance to low concentrations of anirreversible egfr inhibitor
../abc\EGFR\29973561_page4_305_1.jpg,The role of egfr inhibition in the treatment of non-small cell lung cancer
../abc\EGFR\29973561_page4_305_1.jpg,Azd9291 in EGFR inhibitor-resistant non-small-cell lung cancer
../abc\EGFR\29973561_page4_305_1.jpg,Antitumor activity of osimertinib an irreversible mutant-selective EGFRtyrosine kinase inhibitor in nsclc harboring egfr exon 20 insertions
../abc\EGFR\29973561_page4_305_1.jpg,Egfr-independentmechanisms of acquired resistance to azd9291 in egfr t790m-positive nsclc patients
../abc\EGFR\29973561_page4_305_1.jpg,EGFR g796dmutation mediates resistance to osimertinib
../abc\EGFR\29973561_page4_305_1.jpg,EGFR c797s mutation mediates resistance to third-generationinhibitors in t790m-positive non-small cell lung cancer
../abc\EGFR\29973561_page4_305_1.jpg,Eai045: The fourth-generation egfr inhibitor overcoming t790m and c797sresistance
../abc\EGFR\29973561_page4_305_1.jpg,Activating and resistance mutations of egfr in non-small-cell lung cancer: Role in clinicalresponse to EGFR tyrosine kinase inhibitors
../abc\EGFR\29973561_page4_305_1.jpg,T790m and acquired resistance of EGFR TKI: A literature review of clinical reports
../abc\EGFR\29973561_page4_305_1.jpg,Alternative signalingpathways as potential therapeutic targets for overcoming egfr and c-met inhibitor resistance in non-smallcell lung cancer
../abc\EGFR\29973561_page4_305_1.jpg,Mechanism of resistance and novel targetsmediating resistance to egfr and c-met tyrosine kinase inhibitors in non-small cell lung cancer
../abc\EGFR\29973561_page4_305_1.jpg,HER2 kinase domain mutation results in constitutive phosphorylation andactivation of HER2 and EGFR and resistance to egfr tyrosine kinase inhibitors
../abc\EGFR\29973561_page4_305_1.jpg,Synergism of EGFR and c-MET pathways cross-talk and inhibition in non-small celllung cancer
../abc\EGFR\29973561_page4_305_1.jpg,Combined therapy with mutant-selective EGFR inhibitor and MET kinaseinhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer
../abc\EGFR\29973561_page4_305_1.jpg,Combinedinhibition of igfr enhances the effects of geﬁtinib in h1650: A lung cancer cell line with egfr mutation andprimary resistance to EGFR-TK inhibitors
../abc\EGFR\29973561_page4_305_1.jpg,Synergistic effects of metformin treatment in combination with geﬁtinib a selective egfr tyrosine kinase inhibitor in LKB1 wild-type nsclc cell lines
../abc\EGFR\29973561_page4_305_1.jpg,Activation of signal transducer and activator of transcription 3 STAT3 signaling in egfr mutant non-small-cell lung cancer NSCLC
../abc\EGFR\29973561_page4_305_1.jpg,Acquired resistance to the mutant-selective EGFR inhibitor azd9291 is associatedwith increased dependence on Ras signaling in preclinical models
../abc\EGFR\30060526_page55_1599_0.jpg,In this study an attemptwas made to try to understand the mechanisms of resistance to osimertinib in patients with diseaseprogression investigating circulating tumor DNA: 50% of these patients had no-detectable ctDNAand in the remaining patients the molecular mechanisms of tumor resistance were heterogeneous MET ampliﬁcation EGFR and KRAS ampliﬁcation MEK1 KRAS or PI3KC mutations EGFR C797Smutations JAK2 mutations HER2 exon 20 mutation ; importantly there was no evidence of acquiredEGFR T790M mutation in progressing patients treated with osimertinib [331]
../abc\EGFR\30060526_page55_1599_0.jpg,Interestingly the Chinese patients show an increased incidence of NSCLC with EGFR mutationscompared to Caucasian patients [333]
../abc\EGFR\30060526_page55_1599_0.jpg,These tumors are characterized by a mutational MS3 signaturethat is associated with inﬂammatory tumor inﬁltrating B lymphocytes: as a consequence the frequencyof EGFR mutations is very high among lung cancers with a MS3 signature [333]
../abc\EGFR\30060526_page55_1599_0.jpg,According to these observations it was suggested that inﬂammatory inﬁltration maycontribute to the accumulation of EGFR mutations particularly in never-smoker patients
../abc\EGFR\30060526_page55_1599_0.jpg,The various combinations of EGFR mutants determinea spectrum of sensitivity resistance to the various EGFR TKIs and studies are in progress to deﬁneEGFR TKIs able to inhibit NSCLCs bearing triple mutants sensitizing mutations + T790M + C797S :these new mutants such as EA1045 could represent the fourth-generation of EGFR TKIs [334]
../abc\EGFR\30060526_page55_1599_0.jpg,The history of treatments with ALK-rearranged NSCLCs is very similar to that describedfor EGFR mutant patients with progressive identiﬁcation and introduction in clinical use of ﬁrst second and third-generation ALK inhibitors
../abc\EGFR\30060526_page55_1599_0.jpg,The main mechanisms of crizotinib resistance is related to the presence of ROS1resistance mutations particularly of the G2031R ROS1 mutation activation of the wild-type EGFR signaling KRAS andKIT mutations
../abc\EGFR\30060526_page55_1599_0.jpg,Following these guidelines the genes whose alterations have to be tested havebeen grouped into three different categories: a a set of genes that must be offered by all laboratories that test lung cancers including EGFR ALK and ROS1; b a second set of genes that should beincluded in any expanded set of genes including BRAF MET RET ERBB2 and KRAS; c KRAS testingmay be performed also as a single-gene test to exclude patients from expanded panel testing [352 353]
../abc\EGFR\30060526_page55_1599_0.jpg,For patients with LSQCC without EGFR ALK orROS1 alterations the ﬁrst-line therapeutic recommendations are the following: a with high PD-L1expression single-agent pembrolizumab is recommended; b with low PD-L1 expression a varietyof combination cytotoxic chemotherapies are recommended platinum doublet
../abc\EGFR\30060526_page55_1599_0.jpg,The second-linetherapeutic treatment for lung adenocarcinoma patients without a tumor with EGFR ALK andROS1 alterations implies: a in both patients with high PD-L1 expression who received ﬁrst-linechemotherapy and have not received prior immunotherapy and patients with low or unknown tumorPD-L1 expression who received ﬁrst-line chemotherapy single-agent nivolumab atezolizumab orpembrolizumab is recommended; b in patients who received an immune checkpoint inhibitor asﬁrst-line therapy a variety of cytotoxic chemotherapies are recommended; c in patients who receivedcytotoxic chemotherapy and pembrolizumab as ﬁrst-line treatment docetaxel ± ramicirumab orgemcitabine is recommended
../abc\EGFR\30060526_page55_1599_0.jpg,The same applies to patients with LSQCC without EGFR ALK orROS1 alterations for the second-line treatment
../abc\EGFR\30060526_page55_1599_0.jpg,Genome-wide DNA methylation analyses in lung adenocarcinomas:Association with EGFR KRAS and TP53 mutation status gene expression and prognosis
../abc\EGFR\30060526_page55_1599_0.jpg,Clarifying the spectrum of driver oncogene mutations in biomarker-veriﬁedsquamous carcinoma of lung:Lack of EGFR KRAS and presence of PIK3CA AKT1 mutations
../abc\EGFR\30060526_page55_1599_0.jpg,Developemnt of new mouse lung tumor models expressing EGFR T90M mutantsassociated with clinical resistance to kinase inhibitors
../abc\EGFR\30060526_page55_1599_0.jpg,SOX2 expressionis associated with EGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
../abc\EGFR\30060526_page55_1599_0.jpg,Adenosquamous carcinoma of the lung:A microdissection study of KRAS and EGFR mutational ampliﬁcation status in a Western patient population
../abc\EGFR\30060526_page55_1599_0.jpg,Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrationswithin EGFR KRAS and FGFR1: Useful tools for preclinical studies of targeted therapies
../abc\EGFR\30060526_page55_1599_0.jpg,Targeting the FOXO1 KLF6 axis regulates EGFR signaling and treatment response
../abc\EGFR\30060526_page55_1599_0.jpg,EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to Topollinhibitors
../abc\EGFR\30060526_page55_1599_0.jpg,A large-scalecross-sectional study of ALK-rearrangements and EGFR mutations in non-small-cell lung cancer in ChineseHan population
../abc\EGFR\30060526_page55_1599_0.jpg,Afatinib versus geﬁtinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer:Overall survival data from the phase IIb LUX-Lung 7 trial
../abc\EGFR\30060526_page55_1599_0.jpg,Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer
../abc\EGFR\30060526_page55_1599_0.jpg,Osimertinib as ﬁrst-line treatment of EGFR mutation -positive advancednon-small-cell-lung cancer
../abc\EGFR\30424034_page2_147_0.jpg,First-line geﬁtinib in patients with advanced non–small-cell lung cancerharboring somatic EGFR mutations
../abc\EGFR\30424034_page2_147_0.jpg,Epidermal growth factor receptor EGFR tyrosine kinase inhibitors TKIS are effective for leptomeningealmetastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factorsof good response for EGFR TKI
../abc\EGFR\30424034_page2_147_0.jpg,Osimertinib or platinum–pemetrexed in EGFR T790M–positive lungcancer
../abc\EGFR\30424034_page2_147_0.jpg,Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer AURA2 : A multicentre open-label single-arm phase 2 study
../abc\EGFR\30424034_page2_147_0.jpg,Detection of t790m the acquired resistance EGFR mutation by tumorbiopsy versus noninvasive blood-based analyses
../abc\EGFR\30424034_page2_147_0.jpg,A highly sensitive and quantitative test platform for detection ofNSCLC eGFR mutations in urine and plasma
../abc\EGFR\30424034_page2_147_0.jpg,EGFR mutation detection in ctdna from NSCLC patient plasma: A cross-platform comparison of leadingtechnologies to support the clinical development of AZD9291
../abc\EGFR\30424034_page2_147_0.jpg,Prospective validation of rapid plasma genotyping for the detection of EGFR and KRASmutations in advanced lung cancer
../abc\EGFR\30424034_page2_147_0.jpg,Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients withacquired EGFR-TKI resistance
../abc\EGFR\31527477_page12_792_0.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page12_792_0.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page12_792_0.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page12_792_0.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page12_792_0.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page12_792_0.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page12_792_0.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page12_792_0.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page12_792_0.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page12_792_0.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page12_792_0.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page12_792_0.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page12_792_0.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page12_792_0.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page12_792_0.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page12_792_0.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page12_792_0.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page12_792_0.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page12_792_0.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page12_792_0.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page12_792_0.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page12_792_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page12_792_0.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page12_792_0.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page12_792_0.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page12_792_0.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page12_792_0.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page12_792_0.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page12_792_0.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page12_792_0.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page12_792_0.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page12_792_0.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page12_792_0.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page12_792_0.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page12_792_0.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page12_792_0.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\31527477_page3_324_0.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page3_324_0.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page3_324_0.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page3_324_0.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page3_324_0.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page3_324_0.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page3_324_0.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page3_324_0.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page3_324_0.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page3_324_0.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page3_324_0.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page3_324_0.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page3_324_0.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page3_324_0.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page3_324_0.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page3_324_0.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page3_324_0.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page3_324_0.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page3_324_0.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page3_324_0.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page3_324_0.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page3_324_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page3_324_0.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page3_324_0.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page3_324_0.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page3_324_0.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page3_324_0.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page3_324_0.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page3_324_0.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page3_324_0.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page3_324_0.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page3_324_0.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page3_324_0.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page3_324_0.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page3_324_0.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page3_324_0.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\31527477_page5_424_0.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page5_424_0.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page5_424_0.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page5_424_0.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page5_424_0.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page5_424_0.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page5_424_0.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page5_424_0.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page5_424_0.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page5_424_0.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page5_424_0.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page5_424_0.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page5_424_0.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page5_424_0.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page5_424_0.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page5_424_0.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page5_424_0.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page5_424_0.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page5_424_0.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page5_424_0.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page5_424_0.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page5_424_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page5_424_0.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page5_424_0.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page5_424_0.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page5_424_0.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page5_424_0.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page5_424_0.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page5_424_0.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page5_424_0.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page5_424_0.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page5_424_0.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page5_424_0.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page5_424_0.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page5_424_0.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page5_424_0.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\31527477_page6_480_0.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page6_480_0.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page6_480_0.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page6_480_0.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page6_480_0.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page6_480_0.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page6_480_0.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page6_480_0.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page6_480_0.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page6_480_0.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page6_480_0.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page6_480_0.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page6_480_0.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page6_480_0.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page6_480_0.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page6_480_0.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page6_480_0.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page6_480_0.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page6_480_0.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page6_480_0.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page6_480_0.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page6_480_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page6_480_0.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page6_480_0.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page6_480_0.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page6_480_0.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page6_480_0.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page6_480_0.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page6_480_0.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page6_480_0.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page6_480_0.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page6_480_0.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page6_480_0.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page6_480_0.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page6_480_0.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page6_480_0.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\31527477_page6_480_1.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page6_480_1.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page6_480_1.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page6_480_1.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page6_480_1.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page6_480_1.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page6_480_1.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page6_480_1.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page6_480_1.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page6_480_1.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page6_480_1.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page6_480_1.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page6_480_1.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page6_480_1.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page6_480_1.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page6_480_1.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page6_480_1.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page6_480_1.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page6_480_1.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page6_480_1.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page6_480_1.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page6_480_1.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page6_480_1.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page6_480_1.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page6_480_1.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page6_480_1.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page6_480_1.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page6_480_1.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page6_480_1.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page6_480_1.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page6_480_1.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page6_480_1.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page6_480_1.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page6_480_1.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page6_480_1.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page6_480_1.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\31527477_page6_480_2.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page6_480_2.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page6_480_2.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page6_480_2.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page6_480_2.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page6_480_2.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page6_480_2.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page6_480_2.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page6_480_2.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page6_480_2.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page6_480_2.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page6_480_2.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page6_480_2.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page6_480_2.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page6_480_2.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page6_480_2.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page6_480_2.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page6_480_2.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page6_480_2.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page6_480_2.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page6_480_2.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page6_480_2.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page6_480_2.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page6_480_2.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page6_480_2.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page6_480_2.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page6_480_2.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page6_480_2.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page6_480_2.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page6_480_2.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page6_480_2.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page6_480_2.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page6_480_2.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page6_480_2.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page6_480_2.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page6_480_2.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\31527477_page7_566_0.jpg,EGFR tyrosine kinase inhibition induces autophagy in cancercells
../abc\EGFR\31527477_page7_566_0.jpg,RUBCN rubicon and EGFR regulate lysosomaldegradative processes in the retinal pigment epithelium RPE of the eye
../abc\EGFR\31527477_page7_566_0.jpg,Methylation-induced silencing of SPG20 facilitatesgastric cancer cell proliferation by activating the EGFR MAPK pathway
../abc\EGFR\31527477_page7_566_0.jpg,Nicastrin miR-30a-3p RAB31 Axis Regulates Keratinocyte Diﬀerentiation by Impairing EGFR Signaling inFamilial Acne Inversa
../abc\EGFR\31527477_page7_566_0.jpg,Substance-speciﬁcimportance of EGFR for vascular smooth muscle cells motility in primary culture
../abc\EGFR\31527477_page7_566_0.jpg,EGFR tyrosinekinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells
../abc\EGFR\31527477_page7_566_0.jpg,Cathepsin S attenuates endosomal EGFR signalling: Amechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
../abc\EGFR\31527477_page7_566_0.jpg,The tyrosine phosphorylated pro-survival form ofFas intensiﬁes the EGF-induced signal in colorectal cancer cells through the nuclear EGFR STAT3-mediatedpathway
../abc\EGFR\31527477_page7_566_0.jpg,EGFR signaling and autophagy dependence for growth survival and therapyresistance
../abc\EGFR\31527477_page7_566_0.jpg,Targeting EGFR HER2 heterodimerization with a novel anti-HER2 domain II III antibody
../abc\EGFR\31527477_page7_566_0.jpg,EGFR mutations in lung cancer: Correlation with clinical response to geﬁtinib therapy
../abc\EGFR\31527477_page7_566_0.jpg,Structures of lungcancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into diﬀerentialinhibitor sensitivity
../abc\EGFR\31527477_page7_566_0.jpg,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
../abc\EGFR\31527477_page7_566_0.jpg,EGFR G796Dmutation mediates resistance to osimertinib
../abc\EGFR\31527477_page7_566_0.jpg,Combined inhibition of EGFR andc-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
../abc\EGFR\31527477_page7_566_0.jpg,Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancercells
../abc\EGFR\31527477_page7_566_0.jpg,CAPE-pNO2 Inhibited the Growthand Metastasis of Triple-Negative Breast Cancer via the EGFR STAT3 Akt E-Cadherin Signaling Pathway
../abc\EGFR\31527477_page7_566_0.jpg,Stress-Induced EGFR Traﬃcking: Mechanisms Functions and Therapeutic Implications
../abc\EGFR\31527477_page7_566_0.jpg,Positive feedback regulationbetween IL10 and EGFR promotes lung cancer formation
../abc\EGFR\31527477_page7_566_0.jpg,Epidermal growth factor receptor EGFR antibody-induced antibody-dependentcellular cytotoxicity plays a prominent role in inhibiting tumorigenesis even of tumor cells insensitive toEGFR signaling inhibition
../abc\EGFR\31527477_page7_566_0.jpg,Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
../abc\EGFR\31527477_page7_566_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\EGFR\31527477_page7_566_0.jpg,inducible EGFR T790M-mediatedgeﬁtinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provokedautophagy
../abc\EGFR\31527477_page7_566_0.jpg,NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitorerlotinib in head and neck cancer cells
../abc\EGFR\31527477_page7_566_0.jpg,Anactivation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosinekinase inhibitors in lung adenocarcinoma
../abc\EGFR\31527477_page7_566_0.jpg,Blocking autophagy improves the anti-tumor activity of afatinib in lungadenocarcinoma with activating EGFR mutations in vitro and in vivo
../abc\EGFR\31527477_page7_566_0.jpg,The autophagy inhibitor chloroquineovercomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
../abc\EGFR\31527477_page7_566_0.jpg,Combined eﬀects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
../abc\EGFR\31527477_page7_566_0.jpg,Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
../abc\EGFR\31527477_page7_566_0.jpg,MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulatescetuximab sensitivity via EGFR regulation
../abc\EGFR\31527477_page7_566_0.jpg,miR-217 and CAGEform feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
../abc\EGFR\31527477_page7_566_0.jpg,Synergy between next generation EGFR tyrosinekinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
../abc\EGFR\31527477_page7_566_0.jpg,Histone Deacetylase-3 CAGE Axis Targets EGFR Signaling andRegulates the Response to Anti-Cancer Drugs
../abc\EGFR\31527477_page7_566_0.jpg,Dual targeting of EGFR can overcome a major drug resistance mutation in mousemodels of EGFR mutant lung cancer
../abc\EGFR\31527477_page7_566_0.jpg,The Presence of Concomitant Mutations Aﬀects the Activity of EGFR Tyrosine KinaseInhibitors in EGFR-Mutant Non-Small Cell Lung Cancer NSCLC Patients
../abc\EGFR\31527477_page7_566_0.jpg,Targeting the EMT transcription factor TWIST1overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
../abc\EGFR\32516941_page12_150_0.jpg,The combination ofgeﬁtinib and GM-CSF treatment recover T cell inﬁltration in EGFR exon 19 deletion tumors [199]
../abc\EGFR\32516941_page12_150_0.jpg,Theassessment of EGFR mutations for example in plasma exosomes in NSCLC patients could furtherreveal the relevance of the experimental data
../abc\EGFR\32516941_page12_150_0.jpg,Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptiveimmunity
../abc\EGFR\32516941_page12_150_0.jpg,An ex vivo human tumor assay shows distinct patterns of EGFR traﬃcking in squamouscell carcinoma correlating to therapeutic outcomes
../abc\EGFR\32516941_page12_150_0.jpg,Stresshormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with beta-blockers
../abc\EGFR\32516941_page12_150_0.jpg,Anti-epidermal growth factor vaccine antibodiesenhance the eﬃcacy of tyrosine kinase inhibitors and delay the emergence of resistance in EGFR mutantlung cancer cells
../abc\EGFR\32516941_page12_150_0.jpg,Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer
../abc\EGFR\32516941_page12_150_0.jpg,EGFR E746-A750 deletion in lung cancer repressesantitumor immunity through the exosome-mediated inhibition of dendritic cells
../abc\EGFR\32516941_page16_222_0.jpg,The combination ofgeﬁtinib and GM-CSF treatment recover T cell inﬁltration in EGFR exon 19 deletion tumors [199]
../abc\EGFR\32516941_page16_222_0.jpg,Theassessment of EGFR mutations for example in plasma exosomes in NSCLC patients could furtherreveal the relevance of the experimental data
../abc\EGFR\32516941_page16_222_0.jpg,Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptiveimmunity
../abc\EGFR\32516941_page16_222_0.jpg,An ex vivo human tumor assay shows distinct patterns of EGFR traﬃcking in squamouscell carcinoma correlating to therapeutic outcomes
../abc\EGFR\32516941_page16_222_0.jpg,Stresshormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with beta-blockers
../abc\EGFR\32516941_page16_222_0.jpg,Anti-epidermal growth factor vaccine antibodiesenhance the eﬃcacy of tyrosine kinase inhibitors and delay the emergence of resistance in EGFR mutantlung cancer cells
../abc\EGFR\32516941_page16_222_0.jpg,Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer
../abc\EGFR\32516941_page16_222_0.jpg,EGFR E746-A750 deletion in lung cancer repressesantitumor immunity through the exosome-mediated inhibition of dendritic cells
../abc\EGFR\33114576_page2_246_0.jpg,EGFR mutation subtypes and response to immune checkpoint blockade treatment innon-small-cell lung cancer
../abc\EGFR\33114576_page2_246_0.jpg,TP53 STK11 and EGFR mutations predict tumor immune proﬁle andthe response to anti–PD-1 in lung adenocarcinoma
../abc\EGFR\33114576_page2_246_0.jpg,Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib inWildtype Epidermal Growth Factor Receptor EGFR Lung Cancer Cells through Context Speciﬁc PathwaysResulting in Enhanced Therapeutic Eﬃcacy
../abc\EGFR\33114576_page2_246_0.jpg,BIN1 reversesPD-L1-mediated immune escape by inactivating the c-MYC and EGFR MAPK signaling pathways innon-small cell lung cancer
../abc\EGFR\33114576_page2_246_0.jpg,Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non–small cell lung cancer negativefor EGFR mutation and ALK fusion
../abc\EGFR\33114576_page2_246_0.jpg,Atezolizumab plus bevacizumab and chemotherapy innon-small-cell lung cancer IMpower150 : Key subgroup analyses of patients with EGFR mutations orbaseline liver metastases in a randomised open-label phase 3 trial
../abc\EGFR\33562150_page1_85_0.jpg,Advances on EGFR mutation for lung cancer
../abc\EGFR\33562150_page1_85_0.jpg,EGFR Mutations and Resistance toIrreversible Pyrimidine-Based EGFR Inhibitors
../abc\EGFR\33562150_page1_85_0.jpg,Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on aprior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
../abc\EGFR\33562150_page1_85_0.jpg,The next tier of EGFR resistance mutations in lung cancer
../abc\EGFR\33562150_page1_85_0.jpg,Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: AClash of the Generations
../abc\EGFR\33562150_page1_85_0.jpg,An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identiﬁes Axl as a therapeutic targetfor overcoming EGFR inhibitor resistance
../abc\EGFR\33562150_page1_85_0.jpg,Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer
../abc\EGFR\33562150_page1_85_0.jpg,A YAP FOXM1axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
../abc\EGFR\33562150_page1_85_0.jpg,Enhanced YAP expression leads to EGFR TKI resistance in lungadenocarcinomas
../abc\EGFR\33562150_page1_85_0.jpg,YAP-Dependent Axl Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
../abc\EGFR\33562150_page1_85_0.jpg,Targeting histone deacetylase SIRT1selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lungadenocarcinoma
../abc\EGFR\33562150_page1_85_0.jpg,Epithelial-mesenchymal transition EMT beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
../abc\EGFR\33562150_page1_85_0.jpg,PD-L1 confers resistance to EGFR mutation-independent tyrosinekinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression
../abc\EGFR\33562150_page1_85_0.jpg,MERTK Promotes Resistance toIrreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type EGFR Family Members
../abc\EGFR\33562150_page2_105_0.jpg,Advances on EGFR mutation for lung cancer
../abc\EGFR\33562150_page2_105_0.jpg,EGFR Mutations and Resistance toIrreversible Pyrimidine-Based EGFR Inhibitors
../abc\EGFR\33562150_page2_105_0.jpg,Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on aprior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
../abc\EGFR\33562150_page2_105_0.jpg,The next tier of EGFR resistance mutations in lung cancer
../abc\EGFR\33562150_page2_105_0.jpg,Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: AClash of the Generations
../abc\EGFR\33562150_page2_105_0.jpg,An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identiﬁes Axl as a therapeutic targetfor overcoming EGFR inhibitor resistance
../abc\EGFR\33562150_page2_105_0.jpg,Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer
../abc\EGFR\33562150_page2_105_0.jpg,A YAP FOXM1axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
../abc\EGFR\33562150_page2_105_0.jpg,Enhanced YAP expression leads to EGFR TKI resistance in lungadenocarcinomas
../abc\EGFR\33562150_page2_105_0.jpg,YAP-Dependent Axl Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
../abc\EGFR\33562150_page2_105_0.jpg,Targeting histone deacetylase SIRT1selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lungadenocarcinoma
../abc\EGFR\33562150_page2_105_0.jpg,Epithelial-mesenchymal transition EMT beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
../abc\EGFR\33562150_page2_105_0.jpg,PD-L1 confers resistance to EGFR mutation-independent tyrosinekinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression
../abc\EGFR\33562150_page2_105_0.jpg,MERTK Promotes Resistance toIrreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type EGFR Family Members
../abc\ERK\26675306_page3_47_0.jpg,MEK ERK inhibitor U0126 affects in vitro and in vivo growth ofembryonal rhabdomyosarcoma Mol
../abc\ERK\28208579_page7_414_0.jpg,For example TLR2activates JNK and ERK signaling which in turn stimulate phagocytosis and autophagy enhancing thehost innate immune response [172 173]
../abc\ERK\28208579_page7_414_0.jpg,TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes viaextracellular signal-regulated kinase ERK activation
../abc\ERK\29734788_page14_234_0.jpg,Resistance to EGFR inhibitors: EGFR receptors activated by the EGF ligands induce three mainpro-survival signaling pathways: SRC JAK STAT signaling RAS RAF MEK ERK signaling andPI3K AKT mTOR signaling
../abc\ERK\30445769_page5_448_0.jpg,The activation of the AXLby GAS6 leads to activation of the MEK ERK and PI3K AKT pathways and acquired resistanceto EGFR-TKIs [80]
../abc\ERK\31387256_page10_565_0.jpg,1 TOB1 through modulation of the MAPK ERK pathway
../abc\ERK\31387256_page2_203_0.jpg,1 TOB1 through modulation of the MAPK ERK pathway
../abc\ERK\31527477_page7_566_0.jpg,SCH772984 targets ERK activity
../abc\ERK\31527477_page7_566_0.jpg,Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-MediatedPI3K AKT mTOR and ERK p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
../abc\ERK\31988639_page10_712_0.jpg,Signal transductionmediated by the Ras Raf MEK ERK pathway from cytokine receptors to transcription factors: potential targeting fortherapeutic intervention
../abc\ERK\31988639_page10_712_0.jpg,Extracellular signal-regulated kinase ERK regulates cortactinubiquitination and degradation in lung epithelial cells
../abc\ERK\31988639_page10_712_0.jpg,TRAF1 Is Criticalfor Regulating the BRAF MEK ERK Pathway in Non-Small Cell Lung Carcinogenesis
../abc\ERK\31988639_page10_712_0.jpg,Meaningful relationships: the regulation of the Ras Raf MEK ERK pathway by protein interactions
../abc\ERK\31988639_page5_537_0.jpg,Signal transductionmediated by the Ras Raf MEK ERK pathway from cytokine receptors to transcription factors: potential targeting fortherapeutic intervention
../abc\ERK\31988639_page5_537_0.jpg,Extracellular signal-regulated kinase ERK regulates cortactinubiquitination and degradation in lung epithelial cells
../abc\ERK\31988639_page5_537_0.jpg,TRAF1 Is Criticalfor Regulating the BRAF MEK ERK Pathway in Non-Small Cell Lung Carcinogenesis
../abc\ERK\31988639_page5_537_0.jpg,Meaningful relationships: the regulation of the Ras Raf MEK ERK pathway by protein interactions
../abc\ERK\31988639_page5_537_1.jpg,Signal transductionmediated by the Ras Raf MEK ERK pathway from cytokine receptors to transcription factors: potential targeting fortherapeutic intervention
../abc\ERK\31988639_page5_537_1.jpg,Extracellular signal-regulated kinase ERK regulates cortactinubiquitination and degradation in lung epithelial cells
../abc\ERK\31988639_page5_537_1.jpg,TRAF1 Is Criticalfor Regulating the BRAF MEK ERK Pathway in Non-Small Cell Lung Carcinogenesis
../abc\ERK\31988639_page5_537_1.jpg,Meaningful relationships: the regulation of the Ras Raf MEK ERK pathway by protein interactions
../abc\ERK\32549388_page2_94_0.jpg,For example miR-641 wasfound to activate ERK signaling by directly targeting neuroﬁbromatosis
../abc\ERK\33114576_page2_246_0.jpg,EGF: Epidermal Growth Factor; EGFR: Epidermal Growth Factor receptor; EML4-ALK: echinoderm microtubule-associated protein-like 4 gene-anaplastic lymphoma kinase gene; IFN-γ: interferon-gamma; IFN-γR: interferon-gamma receptor; TGF-β1: tumor growth factor beta 1; TKIs: tyrosine kinase inhibitors; VEGF: vascular endothelial growth factor; PD-1: programmed-cell death; PD-L1: programmed-cell death ligand 1; TUSC2: tumor suppressor candidate 2; PI3K: phosphatidylinositol 3-kinase; Akt: Protein kinase B; mTOR: mammalian target of rapamycin; JAK: Janus kinase; STAT: signal transducer and activator of transcription; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; TP53: Tumor protein p53; STK11: Serine threonine kinase 11; DDR: DNA damage response and repair; BRCA1-2: breast cancer type 1 and 2 susceptibility proteins; ATM: Ataxia Telangiectasia Mutated; ATR: ATM related protein; RAS: Rat Sarcoma Viral Oncogene Homolog; MEK: Mitogen-activated ERK kinase; ERK: Extracellular signal-Regulated Kinases; AMPK: 5′ AMP-activated protein kinase; PTEN: Phosphatase and tensin homolog; AP1: Activator protein 1; DNMT1: DNA methyl-transferase 1; IRF: interferon regulatory factor; Me: methyl group P: phosphate group STING: stimulator of interferon genes; HIF-1α: Hypoxia-inducible factor 1-alpha HRE: hypoxia-response element HDAC: Histone deacetylase; HDACi: Histone deacetylase inhibitors; EMT: epithelial–mesenchymal transition; GSK3β: glycogen synthase kinase 3beta
../abc\ERK\33466360_page7_112_0.jpg,The Clinical Effect of the Dual-Targeting Strategy Involving PI3K AKT mTOR and RAS MEK ERK Pathways in Patientswith Advanced Cancer
../abc\MEK\25505733_page1_4_0.jpg,There are ongoing clinical trials assessing BRAF MEK andAKT inhibitors in this population
../abc\MEK\26675306_page3_47_0.jpg,MEK ERK inhibitor U0126 affects in vitro and in vivo growth ofembryonal rhabdomyosarcoma Mol
../abc\MEK\27200298_page4_13_0.jpg,Interim results of a phase II study of the BRAF inhibitor BRAFi dabrafenib D in combination with the MEK inhibitor trametinib T in patients pts with BRAF V600E mutated mut metastatic non-small cell lung cancer NSCLC
../abc\MEK\27938382_page1_9_0.jpg,"ALK anaplastic lymphoma kinase ATR ataxia telangiectasia and Rad3-related protein AXL AXL receptor tyrosine kinase BTK Bruton’s tyrosine kinase CDK 4 6 cyclin-dependent kinase 4 6, CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 dUTPase deoxyuridine triphophatase FAK focal adhesion kinase FGF fibroblast growth factor FLT1 3 fms-like tyrosine kinase 1 3, c-Kit proto-oncogene c-Kit Her2 human epidermal growth factor receptor 2 HLA humanleukocyte antigen IGFR insulin-like growth factor receptor JAK2 Janus kinase 2 MAGEA3 melanoma-associated antigen 3 MAPK mitogen-activated protein kinase MEK mitogen-activated protein kinase kinase mTOR mammalian target of rapamycin NTRK3 neurotrophic tyrosine kinase PARP poly ADP ribose polymerase PDGFR platelet-derived growth factor receptor PI3K phosphatidylinositide 3-kinases sEphB4 soluble extracellular domain of EphB4 Syk spleen tyrosine kinase VEGFR vascular endothelial growth factor receptor VISTA V-domain Ig suppressor of T cell activation WT1 Wilms’ tumor protein"
../abc\MEK\29734788_page14_234_0.jpg,MEK inhibition in non-small cell lung cancer
../abc\MEK\29734788_page14_234_0.jpg,Combined EGFR MEK inhibition prevents the emergence of resistance in EGFR-mutantlung cancer
../abc\MEK\29734788_page6_128_0.jpg,MEK inhibition in non-small cell lung cancer
../abc\MEK\29734788_page6_128_0.jpg,Combined EGFR MEK inhibition prevents the emergence of resistance in EGFR-mutantlung cancer
../abc\MEK\30445769_page5_448_0.jpg,A MAP–ERK kinase MEK inhibitor restored sensitivity to erlotinibin lung cancer which was reduced NF-1 expression in vitro and in vivo [101]
../abc\MEK\31387256_page10_565_0.jpg,"YAP blockade by MEK 1 2, CDK1 CDK9 and YAP-TEAD complex inhibitors in combination with anti-PD-1 PD-L1 ICIs may be a future therapeutic strategy for the treatment of EGFR mutant NSCLC without targetable resistant mutations"
../abc\MEK\31387256_page10_565_0.jpg,The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting ProgrammedDeath 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras p53-Driven Lung Cancer
../abc\MEK\31387256_page2_203_0.jpg,"YAP blockade by MEK 1 2, CDK1 CDK9 and YAP-TEAD complex inhibitors in combination with anti-PD-1 PD-L1 ICIs may be a future therapeutic strategy for the treatment of EGFR mutant NSCLC without targetable resistant mutations"
../abc\MEK\31387256_page2_203_0.jpg,The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting ProgrammedDeath 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras p53-Driven Lung Cancer
../abc\MEK\31438559_page2_103_0.jpg,SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models
../abc\MEK\31438559_page2_103_0.jpg,SHP2 inhibition overcomes RTK-mediated pathway re-activation in KRASmutant tumors treated with MEK inhibitors
../abc\MEK\31438559_page5_145_0.jpg,SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models
../abc\MEK\31438559_page5_145_0.jpg,SHP2 inhibition overcomes RTK-mediated pathway re-activation in KRASmutant tumors treated with MEK inhibitors
../abc\MEK\31527477_page3_324_0.jpg,It is known that RAF and MEK co-inhibitionexhibits synergy in triple negative breast cancer TNBC models [102]
../abc\MEK\31527477_page3_324_0.jpg,It is known that RAF and MEK co-inhibition exhibits synergy in triple negative breast cancer TNBC models [102]
../abc\MEK\31527477_page5_424_0.jpg,It is known that RAF and MEK co-inhibitionexhibits synergy in triple negative breast cancer TNBC models [102]
../abc\MEK\31527477_page5_424_0.jpg,It is known that RAF and MEK co-inhibition exhibits synergy in triple negative breast cancer TNBC models [102]
../abc\MEK\31527477_page7_566_0.jpg,It is known that RAF and MEK co-inhibitionexhibits synergy in triple negative breast cancer TNBC models [102]
../abc\MEK\31527477_page7_566_0.jpg,It is known that RAF and MEK co-inhibition exhibits synergy in triple negative breast cancer TNBC models [102]
../abc\MEK\31988639_page5_537_0.jpg,TRAF1 Is Criticalfor Regulating the BRAF MEK ERK Pathway in Non-Small Cell Lung Carcinogenesis
../abc\MEK\31988639_page5_537_0.jpg,Meaningful relationships: the regulation of the Ras Raf MEK ERK pathway by protein interactions
../abc\MEK\32549388_page2_94_0.jpg,Synergistic interaction between MEK inhibitor and geﬁtinibin EGFR-TKI-resistant human lung cancer cells
../abc\MEK\32549388_page2_94_0.jpg,Combined inhibition of MEK and PI3K pathways overcomes acquired resistance toEGFR-TKIs in non-small cell lung cancer
../abc\MEK\33114576_page2_246_0.jpg,"Similarly the presence of an anaplastic lymphoma kinase ALK rearrangement in NSCLC isassociated with high PD-L1 expression via activation of the MEK ERK, PI3K Akt mTOR pathways andSTAT3 [41–43]"
../abc\MEK\33466360_page7_112_0.jpg,SHP2 InhibitionPrevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
../abc\MEK\33466360_page7_112_0.jpg,Intermittent dosing of RMC-4630 a potent selective inhibitor of SHP2 combined with the MEK inhibitorcobimetinib in a phase 1b 2 clinical trial for advanced solid tumors with activating mutations of RAS signaling
../abc\MEK\33466360_page7_112_0.jpg,Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
../abc\MEK\33466360_page7_112_0.jpg,Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer
../abc\MEK\33466360_page7_112_0.jpg,The Clinical Effect of the Dual-Targeting Strategy Involving PI3K AKT mTOR and RAS MEK ERK Pathways in Patientswith Advanced Cancer
../abc\MEK\33562150_page1_85_0.jpg,was observed in melanoma cells with the BRAF V600E mutation which are resistant toBRAF and MEK inhibitors [85]
../abc\MEK\33562150_page2_105_0.jpg,was observed in melanoma cells with the BRAF V600E mutation which are resistant toBRAF and MEK inhibitors [85]
../abc\MEK\33562150_page4_139_0.jpg,was observed in melanoma cells with the BRAF V600E mutation which are resistant toBRAF and MEK inhibitors [85]
../abc\MEK\33562150_page9_195_0.jpg,was observed in melanoma cells with the BRAF V600E mutation which are resistant toBRAF and MEK inhibitors [85]
../abc\MTOR\23885909_page5_123_0.jpg,SeveralSMKIs are currently in development targeting the PI3K AKT mTOR pathway including PI-103 and OST 906 37
../abc\MTOR\25505733_page1_4_0.jpg,Activated mTOR complexes mTORC1  downstream of PI3K–AKT result in increased ribosomal protein synthesis and furtherAKT activation mTORC2
../abc\MTOR\25505733_page1_4_0.jpg,The mTOR pathway in lung cancer and impli-cations for therapy and biomarker analysis
../abc\MTOR\26579470_page1_13_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\MTOR\26579470_page3_62_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\MTOR\26579470_page7_156_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\MTOR\26675306_page3_47_0.jpg,Maity PI3K AKT mTOR pathway in angiogenesis Front
../abc\MTOR\26675306_page3_47_0.jpg,Effects of small molecule inhibitors of PI3K Akt mTOR signal-ing on neuroblastoma growth in vitro and in vivo Int
../abc\MTOR\26675306_page3_47_0.jpg,The dual PI3K mTOR inhibitor NVP-BEZ235 and chloroquinesynergize to trigger apoptosis via mitochondrial-lysosomal cross-talk Int
../abc\MTOR\26675306_page3_47_0.jpg,Initial testing stage 1 of the mTOR inhibitor rapamycin bythe pediatric preclinical testing program Pediatr
../abc\MTOR\27938382_page1_9_0.jpg,Population pharmacokinetics of PQR309 a dual PI3K mTOR inhibitor inadult patients with advanced solid tumors
../abc\MTOR\28208579_page5_302_0.jpg,LKB1 AMPK mTOR Signaling Pathway in Non-small-cell LungCancer
../abc\MTOR\28208579_page5_302_0.jpg,Making new contacts: The mTOR network in metabolism and signallingcrosstalk
../abc\MTOR\28208579_page5_302_0.jpg,Targeting PI3K Akt mTOR Signaling in Cancer
../abc\MTOR\28208579_page5_302_0.jpg,Insulin signalling to mTOR mediated bythe Akt PKB substrate PRAS40
../abc\MTOR\28208579_page5_302_0.jpg,The LKB1tumor suppressor negatively regulates mTOR signaling
../abc\MTOR\28208579_page5_302_0.jpg,Negative regulation of mTOR activity byLKB1-AMPK signaling in non-small cell lung cancer cells
../abc\MTOR\28208579_page5_302_0.jpg,Impact of dual mTORC1 2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistancein breast cancer in vitro
../abc\MTOR\28208579_page5_302_0.jpg,Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K mTOR inhibition
../abc\MTOR\28208579_page5_302_0.jpg,Perifosine inhibits mammaliantarget of rapamycin signaling through facilitating degradation of major components in the mTOR axis andinduces autophagy
../abc\MTOR\28208579_page5_302_0.jpg,Dual Inhibition of PI3K Akt mTOR Pathway andRole of Autophagy in Non-Small Cell Lung Cancer Cells
../abc\MTOR\28208579_page5_302_0.jpg,Platycodin-D Induced Autophagyin Non-Small Cell Lung Cancer Cells via PI3K Akt mTOR and MAPK Signaling Pathways
../abc\MTOR\29973561_page2_202_0.jpg,Our recent studies indicate that theactivation of alternative signaling pathways such as PI3K mTOR and Wnt may also cause resistanceto EGFR TKIs in certain cell lines with wild-type EGFR; however in cell lines with mutant EGFR there is activation of the mTOR pathway
../abc\MTOR\31527477_page3_324_0.jpg,The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivoby mediating apoptosis and autophagy through regulation of the PI3K Akt mTOR pathway
../abc\MTOR\31527477_page3_324_0.jpg,MTOR inhibition reversed drug resistance after combinationradiation with erlotinib in lung adenocarcinoma
../abc\MTOR\31527477_page3_324_0.jpg,Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-MediatedPI3K AKT mTOR and ERK p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
../abc\MTOR\31527477_page3_324_0.jpg,MicroRNA-495-3pinhibits multidrug resistance by modulating autophagy through GRP78 mTOR axis in gastric cancer
../abc\MTOR\31527477_page5_424_0.jpg,The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivoby mediating apoptosis and autophagy through regulation of the PI3K Akt mTOR pathway
../abc\MTOR\31527477_page5_424_0.jpg,MTOR inhibition reversed drug resistance after combinationradiation with erlotinib in lung adenocarcinoma
../abc\MTOR\31527477_page5_424_0.jpg,Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-MediatedPI3K AKT mTOR and ERK p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
../abc\MTOR\31527477_page5_424_0.jpg,MicroRNA-495-3pinhibits multidrug resistance by modulating autophagy through GRP78 mTOR axis in gastric cancer
../abc\MTOR\31871778_page1_75_0.jpg,Many downstream receptors of the RAS pathways including RAF MEK and mTOR have been studied as potentialtargets in NSCLC in multiple clinical trials
../abc\MTOR\31871778_page1_75_0.jpg,Upstream and downstream of mTOR
../abc\MTOR\31871778_page1_75_0.jpg,Targeting PI3K AKT mTOR pathway in non small cell lung cancer
../abc\MTOR\31920650_page3_84_0.jpg,Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs byactivating the AKT mTOR pathway in EGFR-mutant non-small cell lungcancer
../abc\MTOR\31988639_page10_712_0.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\MTOR\31988639_page10_712_0.jpg,Pathogen signatures activate a ubiquitination pathway that modulates the function of the metaboliccheckpoint kinase mTOR
../abc\MTOR\31988639_page10_712_0.jpg,FBXW7 targets mTOR for degradation andcooperates with PTEN in tumor suppression
../abc\MTOR\31988639_page10_712_0.jpg,Parkin ubiquitinates mTOR to regulate mTORC1 activityunder mitochondrial stress
../abc\MTOR\31988639_page10_712_1.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\MTOR\31988639_page10_712_1.jpg,Pathogen signatures activate a ubiquitination pathway that modulates the function of the metaboliccheckpoint kinase mTOR
../abc\MTOR\31988639_page10_712_1.jpg,FBXW7 targets mTOR for degradation andcooperates with PTEN in tumor suppression
../abc\MTOR\31988639_page10_712_1.jpg,Parkin ubiquitinates mTOR to regulate mTORC1 activityunder mitochondrial stress
../abc\MTOR\31988639_page10_712_2.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\MTOR\31988639_page10_712_2.jpg,Pathogen signatures activate a ubiquitination pathway that modulates the function of the metaboliccheckpoint kinase mTOR
../abc\MTOR\31988639_page10_712_2.jpg,FBXW7 targets mTOR for degradation andcooperates with PTEN in tumor suppression
../abc\MTOR\31988639_page10_712_2.jpg,Parkin ubiquitinates mTOR to regulate mTORC1 activityunder mitochondrial stress
../abc\MTOR\31988639_page10_712_3.jpg,PI3K Akt mTOR signaling pathway and non-small cell lung cancer
../abc\MTOR\31988639_page10_712_3.jpg,Pathogen signatures activate a ubiquitination pathway that modulates the function of the metaboliccheckpoint kinase mTOR
../abc\MTOR\31988639_page10_712_3.jpg,FBXW7 targets mTOR for degradation andcooperates with PTEN in tumor suppression
../abc\MTOR\31988639_page10_712_3.jpg,Parkin ubiquitinates mTOR to regulate mTORC1 activityunder mitochondrial stress
../abc\MTOR\32549388_page2_94_0.jpg,Some miRNAs can promote TKI resistance via activating the PI3K AKT mTOR signaling pathways
../abc\MTOR\32560574_page2_100_0.jpg,described a promising combinatorial strategy using mTOR insulin-like growth factor 1 receptor IGF1R and MEK inhibitors to treat lung tumors bearing KRASallelic substitutions [127]
../abc\MTOR\32560574_page2_100_0.jpg,Phase I trial of MEK 1 2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients withadvanced solid tumors
../abc\MTOR\32560574_page2_100_0.jpg,A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib andPI3K MTOR inhibitor voxtalisib in patients with advanced solid tumours
../abc\MTOR\32560574_page2_100_0.jpg,mTOR mediates a mechanism of resistance to chemotherapy and deﬁnes a rational combinationstrategy to treat KRAS-mutant lung cancer
../abc\MTOR\32666476_page5_83_0.jpg,Allosteric modulation of Ras and the PI3K AKT mTOR pathway: emerging therapeutic opportunities
../abc\MTOR\33114576_page2_246_0.jpg,PI3K Akt mTOR pathway inhibition after progression on PD-1 PD-L1 blockade may overcomeacquired resistance to ICIs secondary to PI3K Akt mTOR upregulation
../abc\MTOR\33114576_page2_246_0.jpg,Trials of combination therapies of PI3K Akt mTOR inhibitors with immunecheckpoint inhibitors are currently ongoing Table 1
../abc\MTOR\33114576_page2_246_0.jpg,The role of mTOR in neuroendocrine tumors: Future cornerstone of a winning strategy? Int
../abc\MTOR\33572782_page2_107_0.jpg,mTOR in Lung Neoplasms
../abc\MTOR\33572782_page2_107_0.jpg,AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
../abc\PI3K\23885909_page5_123_0.jpg,Lapatinib a SMKI promotes apoptosis by inhibiting activation of EGFR andHER-2 and the downstream pathways PI3K AKT mTORand RAS RAF MAPK 45
../abc\PI3K\25505733_page1_4_0.jpg,The PI3K pathway as drug targetin human cancer
../abc\PI3K\25557115_page0_125_0.jpg,NSCLC non-small cell lung cancer; GEF guanine nucleotide exchange factor; GAP GTPase-activating proteins; RTK recep-tor tyrosine kinase; PI3K phosphatidylinositol 3-kinase
../abc\PI3K\26579470_page1_13_0.jpg,The PIK3CA gene encoding a catalytic subunit of the PI3K is mutated or ampliﬁed in various neoplasias including lungcancer
../abc\PI3K\26579470_page1_13_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\PI3K\26579470_page1_13_0.jpg,K-RAS mutant pancreatic tumors show higher sensitivity to MEKthan to PI3K inhibition in vivo
../abc\PI3K\26579470_page2_41_0.jpg,The PIK3CA gene encoding a catalytic subunit of the PI3K is mutated or ampliﬁed in various neoplasias including lungcancer
../abc\PI3K\26579470_page2_41_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\PI3K\26579470_page2_41_0.jpg,K-RAS mutant pancreatic tumors show higher sensitivity to MEKthan to PI3K inhibition in vivo
../abc\PI3K\26579470_page3_62_0.jpg,The PIK3CA gene encoding a catalytic subunit of the PI3K is mutated or ampliﬁed in various neoplasias including lungcancer
../abc\PI3K\26579470_page3_62_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\PI3K\26579470_page3_62_0.jpg,K-RAS mutant pancreatic tumors show higher sensitivity to MEKthan to PI3K inhibition in vivo
../abc\PI3K\26579470_page6_135_0.jpg,The PIK3CA gene encoding a catalytic subunit of the PI3K is mutated or ampliﬁed in various neoplasias including lungcancer
../abc\PI3K\26579470_page6_135_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\PI3K\26579470_page6_135_0.jpg,K-RAS mutant pancreatic tumors show higher sensitivity to MEKthan to PI3K inhibition in vivo
../abc\PI3K\26579470_page7_156_0.jpg,The PIK3CA gene encoding a catalytic subunit of the PI3K is mutated or ampliﬁed in various neoplasias including lungcancer
../abc\PI3K\26579470_page7_156_0.jpg,EMT may be induced bythe activation of AXL via the PI3K AKT pathway
../abc\PI3K\26579470_page7_156_0.jpg,K-RAS mutant pancreatic tumors show higher sensitivity to MEKthan to PI3K inhibition in vivo
../abc\PI3K\26675306_page3_47_0.jpg,Maity PI3K AKT mTOR pathway in angiogenesis Front
../abc\PI3K\26675306_page3_47_0.jpg,Targeting aberrant PI3K Akt activation by PI103 restores sensitivityto TRAIL-induced apoptosis in neuroblastoma Clin
../abc\PI3K\26675306_page3_47_0.jpg,Effects of small molecule inhibitors of PI3K Akt mTOR signal-ing on neuroblastoma growth in vitro and in vivo Int
../abc\PI3K\26675306_page3_47_0.jpg,The dual PI3K mTOR inhibitor NVP-BEZ235 and chloroquinesynergize to trigger apoptosis via mitochondrial-lysosomal cross-talk Int
../abc\PI3K\26675306_page3_47_0.jpg,Interfering with resistance to smoothened antagonists by inhi-bition of the PI3K pathway in medulloblastoma Sci
../abc\PI3K\26922479_page5_250_0.jpg,Targeting PI3K signalling in cancer: opportunities challengesand limitations
../abc\PI3K\26922479_page5_250_0.jpg,Curcumin a dietary component has anticancer chemosensitization and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K mTOR ETS2 pathway
../abc\PI3K\28208579_page7_414_0.jpg,Differential induction of apoptosis in HER2 and EGFR addicted cancersfollowing PI3K inhibition
../abc\PI3K\28208579_page7_414_0.jpg,Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K mTOR inhibition
../abc\PI3K\28208579_page7_414_0.jpg,Dual Inhibition of PI3K Akt mTOR Pathway andRole of Autophagy in Non-Small Cell Lung Cancer Cells
../abc\PI3K\28208579_page7_414_0.jpg,Platycodin-D Induced Autophagyin Non-Small Cell Lung Cancer Cells via PI3K Akt mTOR and MAPK Signaling Pathways
../abc\PI3K\28443282_page1_4_0.jpg,Similar to the MATCH study patients with advanced cancers including NSCLC refractory to standard therapy will undergo a fresh biopsy to identify mutations in one of three path-ways—MAPK PI3K or DNA repair
../abc\PI3K\28443282_page1_4_0.jpg,Phosphoinositide 3-kinase PI3K pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models
../abc\PI3K\28443282_page1_4_0.jpg,Safety and efficacy of buparlisib BKM120 in patients with PI3K pathway-activated non-small cell lung cancer: results from the phase II BASALT-1 study
../abc\PI3K\29734788_page14_234_0.jpg,In another study YAP has been shown to activate AXL tyrosine kinasewhich induces PI3K AKT signaling providing a parallel survival input in the presence of EGFRinhibitors [215 218]
../abc\PI3K\29734788_page6_128_0.jpg,In another study YAP has been shown to activate AXL tyrosine kinasewhich induces PI3K AKT signaling providing a parallel survival input in the presence of EGFRinhibitors [215 218]
../abc\PI3K\29973561_page2_202_0.jpg,The PI3K and MAPK pathways also activate MCL-1 and may provide a route to escape apoptosis and bypass BRAF inhibition
../abc\PI3K\29973561_page2_202_0.jpg,The PI3K and MAPK pathways also activate MCL-1 and may provide a route to escape apoptosis and bypass BRAF inhibition
../abc\PI3K\29973561_page2_202_0.jpg,Signaling intermediates MAPK and PI3K as therapeutic targets innsclc
../abc\PI3K\29973561_page4_305_0.jpg,The PI3K and MAPK pathways also activate MCL-1 and may provide a route to escape apoptosis and bypass BRAF inhibition
../abc\PI3K\29973561_page4_305_0.jpg,The PI3K and MAPK pathways also activate MCL-1 and may provide a route to escape apoptosis and bypass BRAF inhibition
../abc\PI3K\29973561_page4_305_0.jpg,Signaling intermediates MAPK and PI3K as therapeutic targets innsclc
../abc\PI3K\29973561_page9_473_0.jpg,The PI3K and MAPK pathways also activate MCL-1 and may provide a route to escape apoptosis and bypass BRAF inhibition
../abc\PI3K\29973561_page9_473_0.jpg,The PI3K and MAPK pathways also activate MCL-1 and may provide a route to escape apoptosis and bypass BRAF inhibition
../abc\PI3K\29973561_page9_473_0.jpg,Signaling intermediates MAPK and PI3K as therapeutic targets innsclc
../abc\PI3K\31366041_page3_297_0.jpg,"Ras ERK, PI3K Akt and JAK STAT pathways that cumulatively resultin increased proliferation and reduced apoptosis of transformed cells [145]"
../abc\PI3K\31366041_page3_297_0.jpg,Involvement of PI3K Akt pathway in cell cycle progression apoptosis and neoplastic transformation: Atarget for cancer chemotherapy
../abc\PI3K\31404976_page2_190_0.jpg,Targeting the PI3K pathway in cancer: Are we making headway?Nat
../abc\PI3K\31404976_page2_190_0.jpg,MicroRNA-146b promotes PI3K AKT pathwayhyperactivation and thyroid cancer progression by targeting PTEN
../abc\PI3K\31404976_page2_190_0.jpg,MicroRNA-374b accelerates the development oflung cancer through downregulating PTEN expression via activating PI3K Akt pathway
../abc\PI3K\31404976_page2_190_0.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PI3K\31404976_page2_190_0.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PI3K\31404976_page2_190_0.jpg,Alterations ofINPP4B PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung
../abc\PI3K\31404976_page2_190_0.jpg,Phosphoinositide 3-kinase PI3K pathway alterations are associated withhistologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models
../abc\PI3K\31404976_page2_190_1.jpg,Targeting the PI3K pathway in cancer: Are we making headway?Nat
../abc\PI3K\31404976_page2_190_1.jpg,MicroRNA-146b promotes PI3K AKT pathwayhyperactivation and thyroid cancer progression by targeting PTEN
../abc\PI3K\31404976_page2_190_1.jpg,MicroRNA-374b accelerates the development oflung cancer through downregulating PTEN expression via activating PI3K Akt pathway
../abc\PI3K\31404976_page2_190_1.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PI3K\31404976_page2_190_1.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PI3K\31404976_page2_190_1.jpg,Alterations ofINPP4B PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung
../abc\PI3K\31404976_page2_190_1.jpg,Phosphoinositide 3-kinase PI3K pathway alterations are associated withhistologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models
../abc\PI3K\31527477_page3_324_0.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\PI3K\31527477_page3_324_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\PI3K\31527477_page3_324_1.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\PI3K\31527477_page3_324_1.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\PI3K\31527477_page5_424_0.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\PI3K\31527477_page5_424_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\PI3K\31527477_page7_566_0.jpg,MiR-30a-5p Overexpression May OvercomeEGFR-Inhibitor Resistance through Regulating PI3K AKT Signaling Pathway in Non-small Cell Lung CancerCell Lines
../abc\PI3K\31527477_page7_566_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\PI3K\31871778_page1_75_0.jpg,MiR-93 promotes tumorigenesis and metastasis ofnon-small cell lung cancer cells by activating the PI3K Akt pathway via Inhibi-tion of LKB1 PTEN CDKN1A
../abc\PI3K\31871778_page1_75_0.jpg,miRNA-223 is an anticancer gene in human non-small cell lungcancer through the PI3K AKT pathway by targeting EGFR
../abc\PI3K\31871778_page1_75_0.jpg,Targeting PI3K AKT mTOR pathway in non small cell lung cancer
../abc\PI3K\31871778_page1_75_0.jpg,PI3K Akt signalling pathway and cancer
../abc\PI3K\31871778_page1_75_0.jpg,PTEN and PI3K AKT in non-small-cell lung cancer
../abc\PI3K\31871778_page1_75_0.jpg,Inhibition of miR-23a increases the sensitivity of lung cancer stemcells to erlotinib through PTEN PI3K Akt pathway
../abc\PI3K\32466572_page4_127_0.jpg,ROCK1promotes migration and invasion of non-small-cell lung cancer cells through the PTEN PI3K FAK pathway
../abc\PI3K\32466572_page4_127_0.jpg,YAP TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-InducedActivation of the PI3K Pathway
../abc\PI3K\32466572_page4_127_0.jpg,Combined inhibition of MEK and PI3K pathways overcomes acquired resistance toEGFR-TKIs in non-small-cell lung cancer
../abc\PI3K\32466572_page4_127_0.jpg,ERK and p38 MAPK Activities Determine Sensitivity to PI3K mTOR Inhibition viaRegulation of MYC and YAP
../abc\PI3K\32466572_page8_181_0.jpg,ROCK1promotes migration and invasion of non-small-cell lung cancer cells through the PTEN PI3K FAK pathway
../abc\PI3K\32466572_page8_181_0.jpg,YAP TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-InducedActivation of the PI3K Pathway
../abc\PI3K\32466572_page8_181_0.jpg,Combined inhibition of MEK and PI3K pathways overcomes acquired resistance toEGFR-TKIs in non-small-cell lung cancer
../abc\PI3K\32466572_page8_181_0.jpg,ERK and p38 MAPK Activities Determine Sensitivity to PI3K mTOR Inhibition viaRegulation of MYC and YAP
../abc\PI3K\32549388_page2_94_0.jpg,Some miRNAs can promote TKI resistancevia activating the PI3K AKT mTOR signaling pathways
../abc\PI3K\32549388_page2_94_0.jpg,Some miRNAs can promote TKI resistance via activating the PI3K AKT mTOR signaling pathways
../abc\PI3K\32549388_page2_94_0.jpg,Combined inhibition of MEK and PI3K pathways overcomes acquired resistance toEGFR-TKIs in non-small cell lung cancer
../abc\PI3K\32549388_page2_94_0.jpg,Inhibition of miR-23a increases the sensitivity of lungcancer stem cells to erlotinib through PTEN PI3K Akt pathway
../abc\PI3K\32560574_page2_100_0.jpg,KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combinationwith PI3K inhibition
../abc\PI3K\32560574_page2_100_0.jpg,The HSP90 inhibitor NVP-AUY922 attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer
../abc\PI3K\32560574_page2_100_0.jpg,Eﬀective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CAH1047R murine lung cancers
../abc\PI3K\33114576_page2_246_0.jpg,Synergy between the KEAP1 NRF2 and PI3K Pathways DrivesNon-Small-Cell Lung Cancer with an Altered Immune Microenvironment
../abc\PI3K\33114576_page2_246_0.jpg,PD-L1induced by IFN-γ from tumor-associated macrophages via the JAK STAT3 and PI3K AKT signaling pathwayspromoted progression of lung cancer
../abc\PI3K\33114576_page2_246_0.jpg,Safety and Eﬃcacy of Buparlisib BKM120 in Patients with PI3K Pathway-ActivatedNon-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study
../abc\PI3K\33114576_page2_246_0.jpg,Synergic eﬀect of PD-1 blockade and endostaron the PI3K AKT mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model
../abc\PI3K\33435440_page2_101_0.jpg,In addition MET gene ampliﬁcation causesﬁrst generation EGFR-TKI resistance by activating the EGFR-independent phosphorylationof ERBB3 and the downstream activation of the PI3K AKT pathway thus providing abypass mechanism
../abc\PI3K\33562150_page1_85_0.jpg,Incontrast the reduction of MERTK and its downstream signaling pathway by shRNA-mediated knockdown treatment of the MERTK inhibitor BMS-777607 or the PI3K inhibitordecreases PD-L1 expression
../abc\PI3K\33562150_page1_85_0.jpg,An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identiﬁes Axl as a therapeutic targetfor overcoming EGFR inhibitor resistance
../abc\PI3K\33562150_page1_85_0.jpg,EGFR- PI3K -PDK1 pathway regulates YAP signalingin hepatocellular carcinoma: The mechanism and its implications in targeted therapy
../abc\PI3K\33562150_page2_105_0.jpg,Incontrast the reduction of MERTK and its downstream signaling pathway by shRNA-mediated knockdown treatment of the MERTK inhibitor BMS-777607 or the PI3K inhibitordecreases PD-L1 expression
../abc\PI3K\33562150_page2_105_0.jpg,An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identiﬁes Axl as a therapeutic targetfor overcoming EGFR inhibitor resistance
../abc\PI3K\33562150_page2_105_0.jpg,EGFR- PI3K -PDK1 pathway regulates YAP signalingin hepatocellular carcinoma: The mechanism and its implications in targeted therapy
../abc\PI3K\33562150_page4_139_0.jpg,Incontrast the reduction of MERTK and its downstream signaling pathway by shRNA-mediated knockdown treatment of the MERTK inhibitor BMS-777607 or the PI3K inhibitordecreases PD-L1 expression
../abc\PI3K\33562150_page4_139_0.jpg,An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identiﬁes Axl as a therapeutic targetfor overcoming EGFR inhibitor resistance
../abc\PI3K\33562150_page4_139_0.jpg,EGFR- PI3K -PDK1 pathway regulates YAP signalingin hepatocellular carcinoma: The mechanism and its implications in targeted therapy
../abc\PI3K\33562150_page9_195_0.jpg,Incontrast the reduction of MERTK and its downstream signaling pathway by shRNA-mediated knockdown treatment of the MERTK inhibitor BMS-777607 or the PI3K inhibitordecreases PD-L1 expression
../abc\PI3K\33562150_page9_195_0.jpg,An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identiﬁes Axl as a therapeutic targetfor overcoming EGFR inhibitor resistance
../abc\PI3K\33562150_page9_195_0.jpg,EGFR- PI3K -PDK1 pathway regulates YAP signalingin hepatocellular carcinoma: The mechanism and its implications in targeted therapy
../abc\PTEN\26579470_page1_13_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\PTEN\26579470_page1_13_0.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutantlungcancerbyactivationofAktandEGFR
../abc\PTEN\26579470_page3_62_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\PTEN\26579470_page3_62_0.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutantlungcancerbyactivationofAktandEGFR
../abc\PTEN\26579470_page7_156_0.jpg,Inhibition ofthe PI3K AKT mTOR signal pathway can be an effective strategyto NSCLC harboring the EGFR activating mutations that acquiresresistance to both TKIs and radiotherapy due to PTEN loss56
../abc\PTEN\26579470_page7_156_0.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutantlungcancerbyactivationofAktandEGFR
../abc\PTEN\27994551_page3_338_0.jpg,Complete loss of PTEN protein expression correlates with shortertime to brain metastasis and survival in stage IIIB C melanoma patients withBRAFV600 mutations
../abc\PTEN\27994551_page3_338_0.jpg,PTEN opposes negative selection and enables oncogenic transformationof pre-B cells
../abc\PTEN\28443282_page1_4_0.jpg,3 000NCI USANCT02465060AKT inhibitor AZD5363: Akt mutBinimetinib: NRAS mut in codon 12 13 or 61Crizotinib: MET amp exon 14 del; ALK trans; ROS1 trans invDabrafenib +trametinib : BRAF V600Dasatinib: DDR2 S768R I638F or L239R mutDefactinib: NF2 inactivating mutFGFR inhibitor AZD4547: FGFR1–3 amp mut or transNivolumab: mismatch repair deficiencyOsimertinib AZD9291 : EGFR T790MPalbociclib: CCND1 2 or 3 amp + Rb expression by immunohistochemistryPI3Kbeta inhibitor GSK2636771: PTEN mut del expression lossSunitinib maleate: cKIT exon 9 11 13 or 14 mutTaselisib: PTEN loss; PI3K mut or amp without RAS mutTrametinib: BRAF V600 with dabrafenib ; BRAF fusion or non-V600; NF1 mut; GNAQ or GNA11 mutTrastuzumab emtansine: HER2 ampVismodegib: SMO or PTCH1 mutation
../abc\PTEN\31404976_page2_190_0.jpg,Expression and clinical evidence ofmiR-494 and PTEN in non-small cell lung cancer
../abc\PTEN\31404976_page2_190_0.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PTEN\31404976_page2_190_0.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PTEN\31404976_page2_190_0.jpg,Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
../abc\PTEN\31404976_page2_190_0.jpg,In vivo identiﬁcation of tumor- suppressive PTEN ceRNAs in an oncogenicBRAF-induced mouse model of melanoma
../abc\PTEN\31404976_page2_190_0.jpg,PTEN Physically Interacts with and Regulates E2F1-mediated Transcription inLung Cancer
../abc\PTEN\31404976_page2_190_0.jpg,CK1alphasuppresses lung tumour growth by stabilizing PTEN and inducing autophagy
../abc\PTEN\31404976_page2_190_0.jpg,The nuclear transport receptor Importin-11 is a tumor suppressor thatmaintains PTEN protein
../abc\PTEN\31404976_page2_190_0.jpg,The functions and regulation of the PTEN tumour suppressor: New modesand prospects
../abc\PTEN\31404976_page2_190_0.jpg,PTEN regulation by Akt-EGR1-ARF-PTEN axis
../abc\PTEN\31404976_page2_190_0.jpg,Repression of PTEN phosphatase by Snail1 transcriptional factor during gammaradiation-induced apoptosis
../abc\PTEN\31404976_page2_190_0.jpg,Thepolycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymaltransition in human nasopharyngeal epithelial cells
../abc\PTEN\31404976_page2_190_0.jpg,c-Junpromotes cellular survival by suppression of PTEN
../abc\PTEN\31404976_page2_190_0.jpg,Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expressionthrough an NF kappa B-dependent pathway
../abc\PTEN\31404976_page2_190_0.jpg,EYA2 promotes lung cancer cell proliferation by downregulating the expressionof PTEN
../abc\PTEN\31404976_page2_190_0.jpg,Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitorypathway
../abc\PTEN\31404976_page2_190_0.jpg,PTEN andPI3K AKT in non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_0.jpg,Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positivebreast cancer by co-targeting mammalian target of rapamycin protein kinase B or mitogen-activated proteinkinase kinase
../abc\PTEN\31404976_page2_190_0.jpg,Partial PTEN deletion is linked to poor prognosis in breast cancer
../abc\PTEN\31404976_page2_190_0.jpg,Mutation spectrum and genotype-phenotype analyses in Cowden disease andBannayan-Zonana syndrome two hamartoma syndromes with germline PTEN mutation
../abc\PTEN\31404976_page2_190_0.jpg,Loss of phosphataseand tensin homolog PTEN induces leptin-mediated leptin gene expression: Feed-forward loop operatingin the lung
../abc\PTEN\31404976_page2_190_0.jpg,Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mousemodel of lung cancer
../abc\PTEN\31404976_page2_190_0.jpg,Urocanic acid-modiﬁed chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesisin K-ras LA1 mice
../abc\PTEN\31404976_page2_190_0.jpg,Involvement of TGFbeta-induced phosphorylation of the PTEN C-terminus onTGFbeta-induced acquisition of malignant phenotypes in lung cancer cells
../abc\PTEN\31404976_page2_190_0.jpg,Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lungcancers
../abc\PTEN\31404976_page2_190_0.jpg,PTEN mutations and relationship to EGFR ERBB2 KRAS and TP53 mutations in non-small cell lungcancers
../abc\PTEN\31404976_page2_190_0.jpg,The clinical signiﬁcance of loss of FHITand PTEN expression in 289 patients with non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_0.jpg,Loss of PTEN Expression is anIndependent Poor Prognostic Factor in Non-small Cell Lung Cancer
../abc\PTEN\31404976_page2_190_0.jpg,Co-downregulation of PTEN KAI-1 and nm23-H1 tumor metastasis suppressor proteins in non-small celllung cancer
../abc\PTEN\31404976_page2_190_0.jpg,Phosphorylated Akt overexpression and loss of PTEN expressionin non-small cell lung cancer confers poor prognosis
../abc\PTEN\31404976_page2_190_0.jpg,EGFR KRAS BRAF PTEN and PIK3CA mutation in plasmaof small cell lung cancer patients
../abc\PTEN\31404976_page2_190_0.jpg,Mutations in TP53 PIK3CA PTEN and other genes in EGFR mutatedlung cancers: Correlation with clinical outcomes
../abc\PTEN\31404976_page2_190_0.jpg,Identiﬁcation of a subset of human non-small cell lung cancer patients withhigh PI3Kbeta and low PTEN expression more prevalent in squamous cell carcinoma
../abc\PTEN\31404976_page2_190_0.jpg,PTEN expressionis a prognostic marker for patients with non-small cell lung cancer: A systematic review and meta-analysisof the literature
../abc\PTEN\31404976_page2_190_0.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activationof Akt and EGFR
../abc\PTEN\31404976_page2_190_0.jpg,Loss of PTEN expression by blocking nuclear translocation of EGR1in geﬁtinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
../abc\PTEN\31404976_page2_190_0.jpg,Multiple primary lung cancer displaying diﬀerent EGFR and PTEN molecular proﬁles
../abc\PTEN\31404976_page2_190_0.jpg,PPAR-gamma agonist increase geﬁtinib s antitumor activity through PTEN expression
../abc\PTEN\31404976_page2_190_0.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31404976_page2_190_0.jpg,Oncogenic role of the E3 ubiquitin ligase NEDD4-1 a PTEN negative regulator innon-small-cell lung carcinomas
../abc\PTEN\31404976_page2_190_0.jpg,CpG hypermethylation contributesto decreased expression of PTEN during acquired resistance to geﬁtinib in human lung cancer cell lines
../abc\PTEN\31404976_page2_190_0.jpg,PTEN and PIK3CA expression is associatedwith prolonged survival after geﬁtinib treatment in EGFR-mutated lung cancer patients
../abc\PTEN\31404976_page2_190_0.jpg,PTEN status is a crucial determinant of the functional outcome of combinedMEK and mTOR inhibition in cancer
../abc\PTEN\31404976_page2_190_0.jpg,Treg cells require the phosphatase PTEN to restrainTH1 and TFH cell responses
../abc\PTEN\31404976_page2_190_0.jpg,The PTEN pathway in Tregs is a critical driver of the suppressive tumormicroenvironment
../abc\PTEN\31404976_page2_190_0.jpg,Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expressionas a means for tissue quality screening
../abc\PTEN\31404976_page2_190_0.jpg,Loss of PTEN causes SHP2 activation making lungcancer cells unresponsive to IFN-gamma
../abc\PTEN\31404976_page2_190_0.jpg,Eﬀect of PTENinactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophagesin patients with PTEN hamartoma tumor syndrome
../abc\PTEN\31404976_page2_190_0.jpg,PTEN Mutations Trigger Resistance to Immunotherapy
../abc\PTEN\31404976_page2_190_0.jpg,Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint BlockadeTherapy in Metastatic Uterine Leiomyosarcoma
../abc\PTEN\31404976_page2_190_0.jpg,Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
../abc\PTEN\31404976_page2_190_1.jpg,Expression and clinical evidence ofmiR-494 and PTEN in non-small cell lung cancer
../abc\PTEN\31404976_page2_190_1.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PTEN\31404976_page2_190_1.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PTEN\31404976_page2_190_1.jpg,Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
../abc\PTEN\31404976_page2_190_1.jpg,In vivo identiﬁcation of tumor- suppressive PTEN ceRNAs in an oncogenicBRAF-induced mouse model of melanoma
../abc\PTEN\31404976_page2_190_1.jpg,PTEN Physically Interacts with and Regulates E2F1-mediated Transcription inLung Cancer
../abc\PTEN\31404976_page2_190_1.jpg,CK1alphasuppresses lung tumour growth by stabilizing PTEN and inducing autophagy
../abc\PTEN\31404976_page2_190_1.jpg,The nuclear transport receptor Importin-11 is a tumor suppressor thatmaintains PTEN protein
../abc\PTEN\31404976_page2_190_1.jpg,The functions and regulation of the PTEN tumour suppressor: New modesand prospects
../abc\PTEN\31404976_page2_190_1.jpg,PTEN regulation by Akt-EGR1-ARF-PTEN axis
../abc\PTEN\31404976_page2_190_1.jpg,Repression of PTEN phosphatase by Snail1 transcriptional factor during gammaradiation-induced apoptosis
../abc\PTEN\31404976_page2_190_1.jpg,Thepolycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymaltransition in human nasopharyngeal epithelial cells
../abc\PTEN\31404976_page2_190_1.jpg,c-Junpromotes cellular survival by suppression of PTEN
../abc\PTEN\31404976_page2_190_1.jpg,Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expressionthrough an NF kappa B-dependent pathway
../abc\PTEN\31404976_page2_190_1.jpg,EYA2 promotes lung cancer cell proliferation by downregulating the expressionof PTEN
../abc\PTEN\31404976_page2_190_1.jpg,Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitorypathway
../abc\PTEN\31404976_page2_190_1.jpg,PTEN andPI3K AKT in non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_1.jpg,Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positivebreast cancer by co-targeting mammalian target of rapamycin protein kinase B or mitogen-activated proteinkinase kinase
../abc\PTEN\31404976_page2_190_1.jpg,Partial PTEN deletion is linked to poor prognosis in breast cancer
../abc\PTEN\31404976_page2_190_1.jpg,Mutation spectrum and genotype-phenotype analyses in Cowden disease andBannayan-Zonana syndrome two hamartoma syndromes with germline PTEN mutation
../abc\PTEN\31404976_page2_190_1.jpg,Loss of phosphataseand tensin homolog PTEN induces leptin-mediated leptin gene expression: Feed-forward loop operatingin the lung
../abc\PTEN\31404976_page2_190_1.jpg,Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mousemodel of lung cancer
../abc\PTEN\31404976_page2_190_1.jpg,Urocanic acid-modiﬁed chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesisin K-ras LA1 mice
../abc\PTEN\31404976_page2_190_1.jpg,Involvement of TGFbeta-induced phosphorylation of the PTEN C-terminus onTGFbeta-induced acquisition of malignant phenotypes in lung cancer cells
../abc\PTEN\31404976_page2_190_1.jpg,Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lungcancers
../abc\PTEN\31404976_page2_190_1.jpg,PTEN mutations and relationship to EGFR ERBB2 KRAS and TP53 mutations in non-small cell lungcancers
../abc\PTEN\31404976_page2_190_1.jpg,The clinical signiﬁcance of loss of FHITand PTEN expression in 289 patients with non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_1.jpg,Loss of PTEN Expression is anIndependent Poor Prognostic Factor in Non-small Cell Lung Cancer
../abc\PTEN\31404976_page2_190_1.jpg,Co-downregulation of PTEN KAI-1 and nm23-H1 tumor metastasis suppressor proteins in non-small celllung cancer
../abc\PTEN\31404976_page2_190_1.jpg,Phosphorylated Akt overexpression and loss of PTEN expressionin non-small cell lung cancer confers poor prognosis
../abc\PTEN\31404976_page2_190_1.jpg,EGFR KRAS BRAF PTEN and PIK3CA mutation in plasmaof small cell lung cancer patients
../abc\PTEN\31404976_page2_190_1.jpg,Mutations in TP53 PIK3CA PTEN and other genes in EGFR mutatedlung cancers: Correlation with clinical outcomes
../abc\PTEN\31404976_page2_190_1.jpg,Identiﬁcation of a subset of human non-small cell lung cancer patients withhigh PI3Kbeta and low PTEN expression more prevalent in squamous cell carcinoma
../abc\PTEN\31404976_page2_190_1.jpg,PTEN expressionis a prognostic marker for patients with non-small cell lung cancer: A systematic review and meta-analysisof the literature
../abc\PTEN\31404976_page2_190_1.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activationof Akt and EGFR
../abc\PTEN\31404976_page2_190_1.jpg,Loss of PTEN expression by blocking nuclear translocation of EGR1in geﬁtinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
../abc\PTEN\31404976_page2_190_1.jpg,Multiple primary lung cancer displaying diﬀerent EGFR and PTEN molecular proﬁles
../abc\PTEN\31404976_page2_190_1.jpg,PPAR-gamma agonist increase geﬁtinib s antitumor activity through PTEN expression
../abc\PTEN\31404976_page2_190_1.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31404976_page2_190_1.jpg,Oncogenic role of the E3 ubiquitin ligase NEDD4-1 a PTEN negative regulator innon-small-cell lung carcinomas
../abc\PTEN\31404976_page2_190_1.jpg,CpG hypermethylation contributesto decreased expression of PTEN during acquired resistance to geﬁtinib in human lung cancer cell lines
../abc\PTEN\31404976_page2_190_1.jpg,PTEN and PIK3CA expression is associatedwith prolonged survival after geﬁtinib treatment in EGFR-mutated lung cancer patients
../abc\PTEN\31404976_page2_190_1.jpg,PTEN status is a crucial determinant of the functional outcome of combinedMEK and mTOR inhibition in cancer
../abc\PTEN\31404976_page2_190_1.jpg,Treg cells require the phosphatase PTEN to restrainTH1 and TFH cell responses
../abc\PTEN\31404976_page2_190_1.jpg,The PTEN pathway in Tregs is a critical driver of the suppressive tumormicroenvironment
../abc\PTEN\31404976_page2_190_1.jpg,Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expressionas a means for tissue quality screening
../abc\PTEN\31404976_page2_190_1.jpg,Loss of PTEN causes SHP2 activation making lungcancer cells unresponsive to IFN-gamma
../abc\PTEN\31404976_page2_190_1.jpg,Eﬀect of PTENinactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophagesin patients with PTEN hamartoma tumor syndrome
../abc\PTEN\31404976_page2_190_1.jpg,PTEN Mutations Trigger Resistance to Immunotherapy
../abc\PTEN\31404976_page2_190_1.jpg,Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint BlockadeTherapy in Metastatic Uterine Leiomyosarcoma
../abc\PTEN\31404976_page2_190_1.jpg,Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
../abc\PTEN\31404976_page2_190_2.jpg,Expression and clinical evidence ofmiR-494 and PTEN in non-small cell lung cancer
../abc\PTEN\31404976_page2_190_2.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PTEN\31404976_page2_190_2.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PTEN\31404976_page2_190_2.jpg,Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
../abc\PTEN\31404976_page2_190_2.jpg,In vivo identiﬁcation of tumor- suppressive PTEN ceRNAs in an oncogenicBRAF-induced mouse model of melanoma
../abc\PTEN\31404976_page2_190_2.jpg,PTEN Physically Interacts with and Regulates E2F1-mediated Transcription inLung Cancer
../abc\PTEN\31404976_page2_190_2.jpg,CK1alphasuppresses lung tumour growth by stabilizing PTEN and inducing autophagy
../abc\PTEN\31404976_page2_190_2.jpg,The nuclear transport receptor Importin-11 is a tumor suppressor thatmaintains PTEN protein
../abc\PTEN\31404976_page2_190_2.jpg,The functions and regulation of the PTEN tumour suppressor: New modesand prospects
../abc\PTEN\31404976_page2_190_2.jpg,PTEN regulation by Akt-EGR1-ARF-PTEN axis
../abc\PTEN\31404976_page2_190_2.jpg,Repression of PTEN phosphatase by Snail1 transcriptional factor during gammaradiation-induced apoptosis
../abc\PTEN\31404976_page2_190_2.jpg,Thepolycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymaltransition in human nasopharyngeal epithelial cells
../abc\PTEN\31404976_page2_190_2.jpg,c-Junpromotes cellular survival by suppression of PTEN
../abc\PTEN\31404976_page2_190_2.jpg,Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expressionthrough an NF kappa B-dependent pathway
../abc\PTEN\31404976_page2_190_2.jpg,EYA2 promotes lung cancer cell proliferation by downregulating the expressionof PTEN
../abc\PTEN\31404976_page2_190_2.jpg,Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitorypathway
../abc\PTEN\31404976_page2_190_2.jpg,PTEN andPI3K AKT in non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_2.jpg,Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positivebreast cancer by co-targeting mammalian target of rapamycin protein kinase B or mitogen-activated proteinkinase kinase
../abc\PTEN\31404976_page2_190_2.jpg,Partial PTEN deletion is linked to poor prognosis in breast cancer
../abc\PTEN\31404976_page2_190_2.jpg,Mutation spectrum and genotype-phenotype analyses in Cowden disease andBannayan-Zonana syndrome two hamartoma syndromes with germline PTEN mutation
../abc\PTEN\31404976_page2_190_2.jpg,Loss of phosphataseand tensin homolog PTEN induces leptin-mediated leptin gene expression: Feed-forward loop operatingin the lung
../abc\PTEN\31404976_page2_190_2.jpg,Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mousemodel of lung cancer
../abc\PTEN\31404976_page2_190_2.jpg,Urocanic acid-modiﬁed chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesisin K-ras LA1 mice
../abc\PTEN\31404976_page2_190_2.jpg,Involvement of TGFbeta-induced phosphorylation of the PTEN C-terminus onTGFbeta-induced acquisition of malignant phenotypes in lung cancer cells
../abc\PTEN\31404976_page2_190_2.jpg,Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lungcancers
../abc\PTEN\31404976_page2_190_2.jpg,PTEN mutations and relationship to EGFR ERBB2 KRAS and TP53 mutations in non-small cell lungcancers
../abc\PTEN\31404976_page2_190_2.jpg,The clinical signiﬁcance of loss of FHITand PTEN expression in 289 patients with non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_2.jpg,Loss of PTEN Expression is anIndependent Poor Prognostic Factor in Non-small Cell Lung Cancer
../abc\PTEN\31404976_page2_190_2.jpg,Co-downregulation of PTEN KAI-1 and nm23-H1 tumor metastasis suppressor proteins in non-small celllung cancer
../abc\PTEN\31404976_page2_190_2.jpg,Phosphorylated Akt overexpression and loss of PTEN expressionin non-small cell lung cancer confers poor prognosis
../abc\PTEN\31404976_page2_190_2.jpg,EGFR KRAS BRAF PTEN and PIK3CA mutation in plasmaof small cell lung cancer patients
../abc\PTEN\31404976_page2_190_2.jpg,Mutations in TP53 PIK3CA PTEN and other genes in EGFR mutatedlung cancers: Correlation with clinical outcomes
../abc\PTEN\31404976_page2_190_2.jpg,Identiﬁcation of a subset of human non-small cell lung cancer patients withhigh PI3Kbeta and low PTEN expression more prevalent in squamous cell carcinoma
../abc\PTEN\31404976_page2_190_2.jpg,PTEN expressionis a prognostic marker for patients with non-small cell lung cancer: A systematic review and meta-analysisof the literature
../abc\PTEN\31404976_page2_190_2.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activationof Akt and EGFR
../abc\PTEN\31404976_page2_190_2.jpg,Loss of PTEN expression by blocking nuclear translocation of EGR1in geﬁtinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
../abc\PTEN\31404976_page2_190_2.jpg,Multiple primary lung cancer displaying diﬀerent EGFR and PTEN molecular proﬁles
../abc\PTEN\31404976_page2_190_2.jpg,PPAR-gamma agonist increase geﬁtinib s antitumor activity through PTEN expression
../abc\PTEN\31404976_page2_190_2.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31404976_page2_190_2.jpg,Oncogenic role of the E3 ubiquitin ligase NEDD4-1 a PTEN negative regulator innon-small-cell lung carcinomas
../abc\PTEN\31404976_page2_190_2.jpg,CpG hypermethylation contributesto decreased expression of PTEN during acquired resistance to geﬁtinib in human lung cancer cell lines
../abc\PTEN\31404976_page2_190_2.jpg,PTEN and PIK3CA expression is associatedwith prolonged survival after geﬁtinib treatment in EGFR-mutated lung cancer patients
../abc\PTEN\31404976_page2_190_2.jpg,PTEN status is a crucial determinant of the functional outcome of combinedMEK and mTOR inhibition in cancer
../abc\PTEN\31404976_page2_190_2.jpg,Treg cells require the phosphatase PTEN to restrainTH1 and TFH cell responses
../abc\PTEN\31404976_page2_190_2.jpg,The PTEN pathway in Tregs is a critical driver of the suppressive tumormicroenvironment
../abc\PTEN\31404976_page2_190_2.jpg,Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expressionas a means for tissue quality screening
../abc\PTEN\31404976_page2_190_2.jpg,Loss of PTEN causes SHP2 activation making lungcancer cells unresponsive to IFN-gamma
../abc\PTEN\31404976_page2_190_2.jpg,Eﬀect of PTENinactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophagesin patients with PTEN hamartoma tumor syndrome
../abc\PTEN\31404976_page2_190_2.jpg,PTEN Mutations Trigger Resistance to Immunotherapy
../abc\PTEN\31404976_page2_190_2.jpg,Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint BlockadeTherapy in Metastatic Uterine Leiomyosarcoma
../abc\PTEN\31404976_page2_190_2.jpg,Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
../abc\PTEN\31404976_page2_190_3.jpg,Expression and clinical evidence ofmiR-494 and PTEN in non-small cell lung cancer
../abc\PTEN\31404976_page2_190_3.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PTEN\31404976_page2_190_3.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PTEN\31404976_page2_190_3.jpg,Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
../abc\PTEN\31404976_page2_190_3.jpg,In vivo identiﬁcation of tumor- suppressive PTEN ceRNAs in an oncogenicBRAF-induced mouse model of melanoma
../abc\PTEN\31404976_page2_190_3.jpg,PTEN Physically Interacts with and Regulates E2F1-mediated Transcription inLung Cancer
../abc\PTEN\31404976_page2_190_3.jpg,CK1alphasuppresses lung tumour growth by stabilizing PTEN and inducing autophagy
../abc\PTEN\31404976_page2_190_3.jpg,The nuclear transport receptor Importin-11 is a tumor suppressor thatmaintains PTEN protein
../abc\PTEN\31404976_page2_190_3.jpg,The functions and regulation of the PTEN tumour suppressor: New modesand prospects
../abc\PTEN\31404976_page2_190_3.jpg,PTEN regulation by Akt-EGR1-ARF-PTEN axis
../abc\PTEN\31404976_page2_190_3.jpg,Repression of PTEN phosphatase by Snail1 transcriptional factor during gammaradiation-induced apoptosis
../abc\PTEN\31404976_page2_190_3.jpg,Thepolycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymaltransition in human nasopharyngeal epithelial cells
../abc\PTEN\31404976_page2_190_3.jpg,c-Junpromotes cellular survival by suppression of PTEN
../abc\PTEN\31404976_page2_190_3.jpg,Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expressionthrough an NF kappa B-dependent pathway
../abc\PTEN\31404976_page2_190_3.jpg,EYA2 promotes lung cancer cell proliferation by downregulating the expressionof PTEN
../abc\PTEN\31404976_page2_190_3.jpg,Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitorypathway
../abc\PTEN\31404976_page2_190_3.jpg,PTEN andPI3K AKT in non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_3.jpg,Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positivebreast cancer by co-targeting mammalian target of rapamycin protein kinase B or mitogen-activated proteinkinase kinase
../abc\PTEN\31404976_page2_190_3.jpg,Partial PTEN deletion is linked to poor prognosis in breast cancer
../abc\PTEN\31404976_page2_190_3.jpg,Mutation spectrum and genotype-phenotype analyses in Cowden disease andBannayan-Zonana syndrome two hamartoma syndromes with germline PTEN mutation
../abc\PTEN\31404976_page2_190_3.jpg,Loss of phosphataseand tensin homolog PTEN induces leptin-mediated leptin gene expression: Feed-forward loop operatingin the lung
../abc\PTEN\31404976_page2_190_3.jpg,Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mousemodel of lung cancer
../abc\PTEN\31404976_page2_190_3.jpg,Urocanic acid-modiﬁed chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesisin K-ras LA1 mice
../abc\PTEN\31404976_page2_190_3.jpg,Involvement of TGFbeta-induced phosphorylation of the PTEN C-terminus onTGFbeta-induced acquisition of malignant phenotypes in lung cancer cells
../abc\PTEN\31404976_page2_190_3.jpg,Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lungcancers
../abc\PTEN\31404976_page2_190_3.jpg,PTEN mutations and relationship to EGFR ERBB2 KRAS and TP53 mutations in non-small cell lungcancers
../abc\PTEN\31404976_page2_190_3.jpg,The clinical signiﬁcance of loss of FHITand PTEN expression in 289 patients with non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_3.jpg,Loss of PTEN Expression is anIndependent Poor Prognostic Factor in Non-small Cell Lung Cancer
../abc\PTEN\31404976_page2_190_3.jpg,Co-downregulation of PTEN KAI-1 and nm23-H1 tumor metastasis suppressor proteins in non-small celllung cancer
../abc\PTEN\31404976_page2_190_3.jpg,Phosphorylated Akt overexpression and loss of PTEN expressionin non-small cell lung cancer confers poor prognosis
../abc\PTEN\31404976_page2_190_3.jpg,EGFR KRAS BRAF PTEN and PIK3CA mutation in plasmaof small cell lung cancer patients
../abc\PTEN\31404976_page2_190_3.jpg,Mutations in TP53 PIK3CA PTEN and other genes in EGFR mutatedlung cancers: Correlation with clinical outcomes
../abc\PTEN\31404976_page2_190_3.jpg,Identiﬁcation of a subset of human non-small cell lung cancer patients withhigh PI3Kbeta and low PTEN expression more prevalent in squamous cell carcinoma
../abc\PTEN\31404976_page2_190_3.jpg,PTEN expressionis a prognostic marker for patients with non-small cell lung cancer: A systematic review and meta-analysisof the literature
../abc\PTEN\31404976_page2_190_3.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activationof Akt and EGFR
../abc\PTEN\31404976_page2_190_3.jpg,Loss of PTEN expression by blocking nuclear translocation of EGR1in geﬁtinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
../abc\PTEN\31404976_page2_190_3.jpg,Multiple primary lung cancer displaying diﬀerent EGFR and PTEN molecular proﬁles
../abc\PTEN\31404976_page2_190_3.jpg,PPAR-gamma agonist increase geﬁtinib s antitumor activity through PTEN expression
../abc\PTEN\31404976_page2_190_3.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31404976_page2_190_3.jpg,Oncogenic role of the E3 ubiquitin ligase NEDD4-1 a PTEN negative regulator innon-small-cell lung carcinomas
../abc\PTEN\31404976_page2_190_3.jpg,CpG hypermethylation contributesto decreased expression of PTEN during acquired resistance to geﬁtinib in human lung cancer cell lines
../abc\PTEN\31404976_page2_190_3.jpg,PTEN and PIK3CA expression is associatedwith prolonged survival after geﬁtinib treatment in EGFR-mutated lung cancer patients
../abc\PTEN\31404976_page2_190_3.jpg,PTEN status is a crucial determinant of the functional outcome of combinedMEK and mTOR inhibition in cancer
../abc\PTEN\31404976_page2_190_3.jpg,Treg cells require the phosphatase PTEN to restrainTH1 and TFH cell responses
../abc\PTEN\31404976_page2_190_3.jpg,The PTEN pathway in Tregs is a critical driver of the suppressive tumormicroenvironment
../abc\PTEN\31404976_page2_190_3.jpg,Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expressionas a means for tissue quality screening
../abc\PTEN\31404976_page2_190_3.jpg,Loss of PTEN causes SHP2 activation making lungcancer cells unresponsive to IFN-gamma
../abc\PTEN\31404976_page2_190_3.jpg,Eﬀect of PTENinactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophagesin patients with PTEN hamartoma tumor syndrome
../abc\PTEN\31404976_page2_190_3.jpg,PTEN Mutations Trigger Resistance to Immunotherapy
../abc\PTEN\31404976_page2_190_3.jpg,Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint BlockadeTherapy in Metastatic Uterine Leiomyosarcoma
../abc\PTEN\31404976_page2_190_3.jpg,Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
../abc\PTEN\31404976_page2_190_4.jpg,Expression and clinical evidence ofmiR-494 and PTEN in non-small cell lung cancer
../abc\PTEN\31404976_page2_190_4.jpg,MicroRNA-4286 promotescell proliferation migration and invasion via PTEN regulation of the PI3K Akt pathway in non-small celllung cancer
../abc\PTEN\31404976_page2_190_4.jpg,PTEN PTENP1: ’Regulatingthe regulator of RTK-dependent PI3K Akt signalling’ new targets for cancer therapy
../abc\PTEN\31404976_page2_190_4.jpg,Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
../abc\PTEN\31404976_page2_190_4.jpg,In vivo identiﬁcation of tumor- suppressive PTEN ceRNAs in an oncogenicBRAF-induced mouse model of melanoma
../abc\PTEN\31404976_page2_190_4.jpg,PTEN Physically Interacts with and Regulates E2F1-mediated Transcription inLung Cancer
../abc\PTEN\31404976_page2_190_4.jpg,CK1alphasuppresses lung tumour growth by stabilizing PTEN and inducing autophagy
../abc\PTEN\31404976_page2_190_4.jpg,The nuclear transport receptor Importin-11 is a tumor suppressor thatmaintains PTEN protein
../abc\PTEN\31404976_page2_190_4.jpg,The functions and regulation of the PTEN tumour suppressor: New modesand prospects
../abc\PTEN\31404976_page2_190_4.jpg,PTEN regulation by Akt-EGR1-ARF-PTEN axis
../abc\PTEN\31404976_page2_190_4.jpg,Repression of PTEN phosphatase by Snail1 transcriptional factor during gammaradiation-induced apoptosis
../abc\PTEN\31404976_page2_190_4.jpg,Thepolycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymaltransition in human nasopharyngeal epithelial cells
../abc\PTEN\31404976_page2_190_4.jpg,c-Junpromotes cellular survival by suppression of PTEN
../abc\PTEN\31404976_page2_190_4.jpg,Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expressionthrough an NF kappa B-dependent pathway
../abc\PTEN\31404976_page2_190_4.jpg,EYA2 promotes lung cancer cell proliferation by downregulating the expressionof PTEN
../abc\PTEN\31404976_page2_190_4.jpg,Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitorypathway
../abc\PTEN\31404976_page2_190_4.jpg,PTEN andPI3K AKT in non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_4.jpg,Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positivebreast cancer by co-targeting mammalian target of rapamycin protein kinase B or mitogen-activated proteinkinase kinase
../abc\PTEN\31404976_page2_190_4.jpg,Partial PTEN deletion is linked to poor prognosis in breast cancer
../abc\PTEN\31404976_page2_190_4.jpg,Mutation spectrum and genotype-phenotype analyses in Cowden disease andBannayan-Zonana syndrome two hamartoma syndromes with germline PTEN mutation
../abc\PTEN\31404976_page2_190_4.jpg,Loss of phosphataseand tensin homolog PTEN induces leptin-mediated leptin gene expression: Feed-forward loop operatingin the lung
../abc\PTEN\31404976_page2_190_4.jpg,Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mousemodel of lung cancer
../abc\PTEN\31404976_page2_190_4.jpg,Urocanic acid-modiﬁed chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesisin K-ras LA1 mice
../abc\PTEN\31404976_page2_190_4.jpg,Involvement of TGFbeta-induced phosphorylation of the PTEN C-terminus onTGFbeta-induced acquisition of malignant phenotypes in lung cancer cells
../abc\PTEN\31404976_page2_190_4.jpg,Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lungcancers
../abc\PTEN\31404976_page2_190_4.jpg,PTEN mutations and relationship to EGFR ERBB2 KRAS and TP53 mutations in non-small cell lungcancers
../abc\PTEN\31404976_page2_190_4.jpg,The clinical signiﬁcance of loss of FHITand PTEN expression in 289 patients with non-small-cell lung cancer
../abc\PTEN\31404976_page2_190_4.jpg,Loss of PTEN Expression is anIndependent Poor Prognostic Factor in Non-small Cell Lung Cancer
../abc\PTEN\31404976_page2_190_4.jpg,Co-downregulation of PTEN KAI-1 and nm23-H1 tumor metastasis suppressor proteins in non-small celllung cancer
../abc\PTEN\31404976_page2_190_4.jpg,Phosphorylated Akt overexpression and loss of PTEN expressionin non-small cell lung cancer confers poor prognosis
../abc\PTEN\31404976_page2_190_4.jpg,EGFR KRAS BRAF PTEN and PIK3CA mutation in plasmaof small cell lung cancer patients
../abc\PTEN\31404976_page2_190_4.jpg,Mutations in TP53 PIK3CA PTEN and other genes in EGFR mutatedlung cancers: Correlation with clinical outcomes
../abc\PTEN\31404976_page2_190_4.jpg,Identiﬁcation of a subset of human non-small cell lung cancer patients withhigh PI3Kbeta and low PTEN expression more prevalent in squamous cell carcinoma
../abc\PTEN\31404976_page2_190_4.jpg,PTEN expressionis a prognostic marker for patients with non-small cell lung cancer: A systematic review and meta-analysisof the literature
../abc\PTEN\31404976_page2_190_4.jpg,PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activationof Akt and EGFR
../abc\PTEN\31404976_page2_190_4.jpg,Loss of PTEN expression by blocking nuclear translocation of EGR1in geﬁtinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
../abc\PTEN\31404976_page2_190_4.jpg,Multiple primary lung cancer displaying diﬀerent EGFR and PTEN molecular proﬁles
../abc\PTEN\31404976_page2_190_4.jpg,PPAR-gamma agonist increase geﬁtinib s antitumor activity through PTEN expression
../abc\PTEN\31404976_page2_190_4.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31404976_page2_190_4.jpg,Oncogenic role of the E3 ubiquitin ligase NEDD4-1 a PTEN negative regulator innon-small-cell lung carcinomas
../abc\PTEN\31404976_page2_190_4.jpg,CpG hypermethylation contributesto decreased expression of PTEN during acquired resistance to geﬁtinib in human lung cancer cell lines
../abc\PTEN\31404976_page2_190_4.jpg,PTEN and PIK3CA expression is associatedwith prolonged survival after geﬁtinib treatment in EGFR-mutated lung cancer patients
../abc\PTEN\31404976_page2_190_4.jpg,PTEN status is a crucial determinant of the functional outcome of combinedMEK and mTOR inhibition in cancer
../abc\PTEN\31404976_page2_190_4.jpg,Treg cells require the phosphatase PTEN to restrainTH1 and TFH cell responses
../abc\PTEN\31404976_page2_190_4.jpg,The PTEN pathway in Tregs is a critical driver of the suppressive tumormicroenvironment
../abc\PTEN\31404976_page2_190_4.jpg,Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expressionas a means for tissue quality screening
../abc\PTEN\31404976_page2_190_4.jpg,Loss of PTEN causes SHP2 activation making lungcancer cells unresponsive to IFN-gamma
../abc\PTEN\31404976_page2_190_4.jpg,Eﬀect of PTENinactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophagesin patients with PTEN hamartoma tumor syndrome
../abc\PTEN\31404976_page2_190_4.jpg,PTEN Mutations Trigger Resistance to Immunotherapy
../abc\PTEN\31404976_page2_190_4.jpg,Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint BlockadeTherapy in Metastatic Uterine Leiomyosarcoma
../abc\PTEN\31404976_page2_190_4.jpg,Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
../abc\PTEN\31871778_page1_75_0.jpg,Alteration in Mir-21 PTEN expression modulates geﬁtinib resis-tance in non-small cell lung cancer
../abc\PTEN\31871778_page1_75_0.jpg,Inhibition of miR-23a increases the sensitivity of lung cancer stemcells to erlotinib through PTEN PI3K Akt pathway
../abc\PTEN\31920650_page1_28_0.jpg,MicroRNA-21 miR-21 regulates cellular proliferation invasion migration andapoptosis by targeting PTEN RECK and Bcl-2 in lung squamous carcinoma Gejiu City China
../abc\PTEN\31920650_page1_28_0.jpg,miR-21confers cisplatin resistance in gastric cancer cells by regulating PTEN
../abc\PTEN\31988639_page5_537_0.jpg,PTEN regulates the ubiquitin-dependentdegradation of the CDK inhibitor p27 KIP1 through the ubiquitin E3 ligase SCF SKP2
../abc\PTEN\31988639_page5_537_0.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31988639_page5_537_0.jpg,WWP2 is an E3 ubiquitin ligase for PTEN
../abc\PTEN\31988639_page5_537_0.jpg,The ubiquitin ligase Nedd4-1 isdispensable for the regulation of PTEN stability and localization
../abc\PTEN\31988639_page5_537_0.jpg,The deubiquitinylation andlocalization of PTEN are regulated by a HAUSP-PML network
../abc\PTEN\31988639_page5_537_0.jpg,Deubiquitylation andstabilization of PTEN by USP13
../abc\PTEN\31988639_page5_537_0.jpg,Deregulation of the EGFR PI3K PTEN Akt mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
../abc\PTEN\31988639_page5_537_0.jpg,Combinatorial antitumor effect of HDAC and thePI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer
../abc\PTEN\31988639_page5_537_0.jpg,FBXW7 targets mTOR for degradation andcooperates with PTEN in tumor suppression
../abc\PTEN\31988639_page9_694_0.jpg,PTEN regulates the ubiquitin-dependentdegradation of the CDK inhibitor p27 KIP1 through the ubiquitin E3 ligase SCF SKP2
../abc\PTEN\31988639_page9_694_0.jpg,NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
../abc\PTEN\31988639_page9_694_0.jpg,WWP2 is an E3 ubiquitin ligase for PTEN
../abc\PTEN\31988639_page9_694_0.jpg,The ubiquitin ligase Nedd4-1 isdispensable for the regulation of PTEN stability and localization
../abc\PTEN\31988639_page9_694_0.jpg,The deubiquitinylation andlocalization of PTEN are regulated by a HAUSP-PML network
../abc\PTEN\31988639_page9_694_0.jpg,Deubiquitylation andstabilization of PTEN by USP13
../abc\PTEN\31988639_page9_694_0.jpg,Deregulation of the EGFR PI3K PTEN Akt mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
../abc\PTEN\31988639_page9_694_0.jpg,Combinatorial antitumor effect of HDAC and thePI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer
../abc\PTEN\31988639_page9_694_0.jpg,FBXW7 targets mTOR for degradation andcooperates with PTEN in tumor suppression
../abc\PTEN\33114576_page2_246_0.jpg,MiR-142-5p regulates CD4+ T cells in human non-small cell lung cancerthrough PD-L1 expression via the PTEN pathway
../abc\STAT3\26579470_page1_13_0.jpg,Activation of IL-6R JAK1 STAT3 signaling induces de novo resis-tance to irreversible EGFR inhibitors in non-small cell lung cancerwith T790M resistance mutation
../abc\STAT3\26579470_page1_13_1.jpg,Activation of IL-6R JAK1 STAT3 signaling induces de novo resis-tance to irreversible EGFR inhibitors in non-small cell lung cancerwith T790M resistance mutation
../abc\STAT3\26579470_page2_41_0.jpg,Activation of IL-6R JAK1 STAT3 signaling induces de novo resis-tance to irreversible EGFR inhibitors in non-small cell lung cancerwith T790M resistance mutation
../abc\STAT3\26579470_page3_62_0.jpg,Activation of IL-6R JAK1 STAT3 signaling induces de novo resis-tance to irreversible EGFR inhibitors in non-small cell lung cancerwith T790M resistance mutation
../abc\STAT3\26579470_page3_62_1.jpg,Activation of IL-6R JAK1 STAT3 signaling induces de novo resis-tance to irreversible EGFR inhibitors in non-small cell lung cancerwith T790M resistance mutation
../abc\STAT3\26579470_page7_156_0.jpg,Activation of IL-6R JAK1 STAT3 signaling induces de novo resis-tance to irreversible EGFR inhibitors in non-small cell lung cancerwith T790M resistance mutation
../abc\STAT3\29692736_page5_330_0.jpg,Lastly lncRNA-ATB activates the autocrine inductionof IL-11 by binding to IL-11 and then activates STAT3 signalingto promote cancer cell colonization Figure 1
../abc\STAT3\31366041_page3_297_0.jpg,Activated nuclear STAT3 has been implicated in maintainingcell survival by controlling the transcription of apoptosis-regulating proteins e
../abc\STAT3\31366041_page3_297_0.jpg,PLCγ unlike STAT3 does notappear to be involved in mediating anti-apoptotic responses [35]
../abc\STAT3\31366041_page3_297_0.jpg,Loss of SHP1 enhances JAK3 STAT3 signaling and decreases proteosome degradation ofJAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
../abc\STAT3\31366041_page3_297_0.jpg,Anaplastic lymphomakinase ALK activates Stat3 and protects hematopoietic cells from cell death
../abc\STAT3\31366041_page3_297_0.jpg,STAT3 induces transcriptionof the DNA methyltransferase 1 gene DNMT1 in malignant T lymphocytes
../abc\STAT3\31366041_page4_358_0.jpg,Activated nuclear STAT3 has been implicated in maintainingcell survival by controlling the transcription of apoptosis-regulating proteins e
../abc\STAT3\31366041_page4_358_0.jpg,PLCγ unlike STAT3 does notappear to be involved in mediating anti-apoptotic responses [35]
../abc\STAT3\31366041_page4_358_0.jpg,Loss of SHP1 enhances JAK3 STAT3 signaling and decreases proteosome degradation ofJAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
../abc\STAT3\31366041_page4_358_0.jpg,Anaplastic lymphomakinase ALK activates Stat3 and protects hematopoietic cells from cell death
../abc\STAT3\31366041_page4_358_0.jpg,STAT3 induces transcriptionof the DNA methyltransferase 1 gene DNMT1 in malignant T lymphocytes
../abc\STAT3\31527477_page3_324_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page3_324_0.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page3_324_0.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page6_480_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page6_480_0.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page6_480_0.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page6_480_1.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page6_480_1.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page6_480_1.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_0.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_0.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_0.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_1.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_1.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_1.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_2.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_2.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_2.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_3.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_3.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_3.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_4.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_4.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_4.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_5.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_5.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_5.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31527477_page7_566_6.jpg,Induction of apoptosis by morusin in human non-smallcell lung cancer cells by suppression of EGFR STAT3 activation
../abc\STAT3\31527477_page7_566_6.jpg,Stat3 signaling in acute myeloid leukemia:Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3inhibitor
../abc\STAT3\31527477_page7_566_6.jpg,Biochemical Properties of a DecoyOligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
../abc\STAT3\31554160_page3_227_0.jpg,Requirementof Stat3 but Not Stat1 Activation for Epidermal Growth Factor Receptor-Mediated Cell Growth in Vitro
../abc\STAT3\31554160_page3_227_0.jpg,STAT3 Activation Abrogates Growth Factor Dependence and Contributes to Head and Neck Squamous CellCarcinoma Tumor Growth in Vivo
../abc\STAT3\31554160_page3_227_1.jpg,Requirementof Stat3 but Not Stat1 Activation for Epidermal Growth Factor Receptor-Mediated Cell Growth in Vitro
../abc\STAT3\31554160_page3_227_1.jpg,STAT3 Activation Abrogates Growth Factor Dependence and Contributes to Head and Neck Squamous CellCarcinoma Tumor Growth in Vivo
../abc\STAT3\31554160_page8_364_0.jpg,Requirementof Stat3 but Not Stat1 Activation for Epidermal Growth Factor Receptor-Mediated Cell Growth in Vitro
../abc\STAT3\31554160_page8_364_0.jpg,STAT3 Activation Abrogates Growth Factor Dependence and Contributes to Head and Neck Squamous CellCarcinoma Tumor Growth in Vivo
../abc\STAT3\31554160_page8_364_1.jpg,Requirementof Stat3 but Not Stat1 Activation for Epidermal Growth Factor Receptor-Mediated Cell Growth in Vitro
../abc\STAT3\31554160_page8_364_1.jpg,STAT3 Activation Abrogates Growth Factor Dependence and Contributes to Head and Neck Squamous CellCarcinoma Tumor Growth in Vivo
../abc\STAT3\31681582_page4_156_0.jpg,JAK1 STAT3 activation through a proinﬂammatorycytokine pathway leads to resistance to molecularly targeted therapyin non-small cell lung cancer
../abc\STAT3\31681582_page4_156_1.jpg,JAK1 STAT3 activation through a proinﬂammatorycytokine pathway leads to resistance to molecularly targeted therapyin non-small cell lung cancer
../abc\STAT3\33114576_page2_246_0.jpg,PD-L1induced by IFN-γ from tumor-associated macrophages via the JAK STAT3 and PI3K AKT signaling pathwayspromoted progression of lung cancer
../abc\STAT3\33114576_page2_246_1.jpg,PD-L1induced by IFN-γ from tumor-associated macrophages via the JAK STAT3 and PI3K AKT signaling pathwayspromoted progression of lung cancer
../abc\STAT3\33114576_page2_247_0.jpg,PD-L1induced by IFN-γ from tumor-associated macrophages via the JAK STAT3 and PI3K AKT signaling pathwayspromoted progression of lung cancer
../abc\STAT3\33121202_page4_150_0.jpg,concluded that miR-204inhibits angiogenesis in LUAD probably via theJAK2 STAT3 pathway
../abc\STAT3\33121202_page4_150_0.jpg,JAK2 STAT3 signaling pathwayactivation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer
../abc\STAT3\33121202_page4_150_0.jpg,mTORC1 drives HIF-1alpha and VEGF-A signallingvia multiple mechanisms involving 4E-BP1 S6K1 and STAT3
../abc\STAT3\33121202_page4_150_0.jpg,MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the14-3-3zeta STAT3 HIF-1alpha VEGF signaling
../abc\STAT3\33121202_page4_150_0.jpg,miR-210 transferred by lung cancer cell-derived exosomes may actas proangiogenic factor in cancer-associated ﬁbroblasts by modulating JAK2 STAT3 pathway
../abc\STAT3\33121202_page4_150_0.jpg,Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
../abc\STAT3\33121202_page4_150_1.jpg,concluded that miR-204inhibits angiogenesis in LUAD probably via theJAK2 STAT3 pathway
../abc\STAT3\33121202_page4_150_1.jpg,JAK2 STAT3 signaling pathwayactivation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer
../abc\STAT3\33121202_page4_150_1.jpg,mTORC1 drives HIF-1alpha and VEGF-A signallingvia multiple mechanisms involving 4E-BP1 S6K1 and STAT3
../abc\STAT3\33121202_page4_150_1.jpg,MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the14-3-3zeta STAT3 HIF-1alpha VEGF signaling
../abc\STAT3\33121202_page4_150_1.jpg,miR-210 transferred by lung cancer cell-derived exosomes may actas proangiogenic factor in cancer-associated ﬁbroblasts by modulating JAK2 STAT3 pathway
../abc\STAT3\33121202_page4_150_1.jpg,Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
../abc\STAT3\33121202_page4_150_2.jpg,concluded that miR-204inhibits angiogenesis in LUAD probably via theJAK2 STAT3 pathway
../abc\STAT3\33121202_page4_150_2.jpg,JAK2 STAT3 signaling pathwayactivation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer
../abc\STAT3\33121202_page4_150_2.jpg,mTORC1 drives HIF-1alpha and VEGF-A signallingvia multiple mechanisms involving 4E-BP1 S6K1 and STAT3
../abc\STAT3\33121202_page4_150_2.jpg,MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the14-3-3zeta STAT3 HIF-1alpha VEGF signaling
../abc\STAT3\33121202_page4_150_2.jpg,miR-210 transferred by lung cancer cell-derived exosomes may actas proangiogenic factor in cancer-associated ﬁbroblasts by modulating JAK2 STAT3 pathway
../abc\STAT3\33121202_page4_150_2.jpg,Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
